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TARGETING EARLY VASCULAR DYSFUNCTION FOLLOWING SPINAL CORD 
INJURY 
The vascular network highly coordinates with the central nervous system (CNS) on 
exchanging oxygen, nutrients and information transfer. The resemblance of the two 
systems at anatomical, cellular, and molecular levels also demonstrates their 
interdependence. The spinal cord is an integrated part of the CNS. Traumatic spinal cord 
injury (SCI) causes rapid systemic vascular responses and local neural tissue damage at the 
initial phase. The early disruption of the spinal vasculature breaks the supply-and-demand 
balance and facilitates the deterioration of the spinal cord tissue and functional deficits. 
Therefore, it is important to dissect the mechanism underlying vascular injury-mediated 
histological and functional consequences in order to develop potential therapeutic 
strategies. 
To visualize dynamic vascular changes after an acute SCI, a novel duo-color in vivo 
imaging technique was successfully developed in adult rats at the cervical level. This 
technique overcomes previous technical hurdles allowing real-time observation of vascular 
changes in live animals. Correlated with histological measures, in vivo vascular outcomes 
revealed a temporospatial relationship with neuronal and axonal loss, myelin disruption, 
inflammation, and glial responses. For the first time, we defined a “transitional zone” 
where significant blood vessel dilation and vascular leakage were observed simultaneously 
with vascular changes occurred at the injury epicenter acutely after SCI. These vascular 
changes at the transitional zone happened before any other cellular damage after SCI, 
suggesting a time window to prevent further neuronal damage in this region. Targeting the 
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observed vascular leakage can work as a proof of concept that early vascular dysfunction 
contributes to the secondary neural tissue damage. Indeed, intravenous delivery of ferulic 
acid conjugated with glycol chitosan (FA-GC) to the injured sites immediate after SCI 
resulted in reduced vascular leakage, ventral horn neuronal loss, and partial recovery of 
forelimb function following a clinically-relevant contusive SCI at the 7th cervical spinal 
cord level.  
In conclusion, this work elucidated a novel role and mechanism of early vascular 
damage in the “transitional zone” prior to the secondary damage of neural tissue in this 
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Spinal cord injury (SCI) is one of most challenging worldwide medical conditions that 
patients suffer either high mortality or lifelong disability accompanying with permanent 
and profound neurologic deficits (Singh et al., 2014, NSCISC, 2019). Following SCI, the 
integrity of vascular structures is disrupted (Benton and Hagg, 2011). Ultrastructural 
studies show vascular pathology minutes after SCI (Goodman et al., 1979, Koyanagi et al., 
1993a) and this is consistent throughout the acute injury phase (Whetstone et al., 2003, 
Benton et al., 2008). In fact, blood vessel endothelial cells appear to be the first cells that 
are vulnerable to the insult from a contusive SCI (Griffiths et al., 1978, Casella et al., 2006). 
These immediate vascular events, including increased permeability of the blood-spinal 
cord-barrier (BSCB), induce edema and contribute to detrimental secondary injury events, 
resulting in histopathology and functional deficits (Benton et al., 2009a, Nelson et al., 
1977). Since vascular injury is a hallmark of SCI, targeting its disruption may represent a 
promising strategy as the preservation of metabolic support of spinal tissue spared by the 
primary injury should result in an enhanced substrate for functional recovery (Benton et 
al., 2009a). To date, research on vascular injury and repair remains to be a largely 
underexplored therapeutic avenue and an urgent medical need.  
To emphasize the necessity to study vascular injury following SCI, the following 
sections address a few fundamental topics. First, this chapter delivers an overview of the 
vascular supply of the spinal cord and the Blood-CNS barriers. Second, I cover the topics 
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including vascular responses to SCI, and current limitations/challenge to study vascular 
injury, and knowledge gap. Finally, I go over the strategies I chose to tackle these research 
questions. 
 
The vascular system of the spinal cord 
The rat model highly resembles the human spinal cord blood supply except for minor 
differences. Therefore, it is frequently used as an experimental model for spinal cord injury. 
The normal vascular supply to the spinal cord can be divided into two main systems: the 
arterial supply and the venous drainage. The arterial supply system replenishes oxygen and 
nutrients, and the venous drainage system takes away carbon dioxide and waste products. 
These two systems connect via the capillary network in local tissues to fulfill the blood 
circulatory functions. 
The segmental spinal branches support the major arterial supply to the spinal cord. 
The origins of the segmental spinal branches differ in different spinal cord regions. In the 
cervical spinal cord, the vertebral arteries (VA) give rises to segmental spinal branches. 
Both lateral VAs come from subclavian arteries. Posterior inferior cerebellar arteries 
(PICA) also supplies the most cranial part of the 1st segment of the cervical spinal cord. In 
the thoracolumbar region, segmental spinal branches arise from dorsal intercostal arteries 
(DIA) and lumbar arteries (LA), which mainly originate from the descending thoracic aorta 
and subclavian arteries (Mazensky et al., 2017). In this particular study of a cervical SCI, 
I mainly focus on the blood supply of the cervical spinal cord. The cervical segmental 
spinal branches, arising from the VAs, enter the spinal cord through the intervertebral 
foramina accompanied with the corresponding nerve roots. Some of the spinal branches 
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divide into ventral spinal arteries (VSA) and dorsal spinal arteries (DSAs) extending in 
longitudinal direction. VSA is lying in the ventral median fissure, and DSAs are near the 
entry zone of dorsal root in gray matter. Small branches, budding from both VSA and 
DSAs, form a spinal arterial ring on the surface of the spinal cord (Turnbull, 1973). This 
constitutes the extrinsic arteries of the spinal cord. The intrinsic arterial system can be 
further categorized into a central and a peripheral circuit. In the central circuit, the sulcal 
arteries branch off the VSA and enter the central gray matter area to supply most of the 
spinal cord gray matter in a centrifugal direction. The peripheral circuit includes a 
centripetal blood flow coming from the extrinsic arteries to supply the peripheral part of 
the spinal cord via small perforating arteries (Griessenauer et al., 2015). In the cervical 
spinal cord, the supply from the peripheral and central systems are approximately equal 
(Turnbull, 1973). Most importantly, the gray matter often presents with a higher density of 
microvasculature compared to the white matter of the spinal cord. Also, the spinal cord is 
much less vascularized than the brain. This may contribute to the outcome of cavitation 
often seen after a spinal cord injury, but not a traumatic brain injury (Losey and Anthony, 
2014). 
The spinal venous network can be divided into intrinsic, extrinsic and extradural 
components. The intrinsic system is separated into central and peripheral sections. In the 
central section, there are two axially-orientated veins: dorsal sulcal vein (DSV) and ventral 
sulcal vein (VSV). These veins collect deoxygenated blood from nearby capillary 
networks. Unlike the ventral dominance presented in the arterial supply system, both the 
DSV and VSV drain equally from the spinal cord. The DSV drains from dorsal gray matter 
and white matter, while the VSV collects blood from a ventral part of gray matter and white 
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matter. The number of sulcal veins varies along the length of the spinal cord. In the cervical 
spinal cord, VSV is 4-8 per cm with the vessel diameter ranging from 100 to 200 µm; DSV 
is 4-6 per cm with a diameter range of 100-300 µm (Moes and Maillot, 1981, Lasjaunias 
and A., 1990, Thron and Rossberg, 1988). In the peripheral section, these axially-orientated 
periphery forming radial veins drain blood from these capillaries from the peripheral part 
of white matter and gray matter. Together with sulcal veins, the radial veins form an 
intricate network of anastomoses with small branches within the central and peripheral 
sections. Besides the axially-orientated veins, there is also longitudinal intrinsic 
anastomosis in both gray and white matter. In the periphery, there is a structure called 
“intersegmental bridges” linking between radial veins at the spinal pial level. These bridges 
are considered the extrinsic venous system. The extrinsic venous system includes three 
components: pial venous network, the longitudinally-orientated extrinsic venous system 
(ventral median vein and dorsal median vein), and radicular veins. The first two are 
considered as collectors, draining from the intrinsic system. The radiculomedullary veins, 
also called radicular veins, connect the extrinsic to the extradural system and receive blood 
from the ventral or dorsal median veins (Santillan et al., 2012). The radicular veins then 
drain into the vertebral venous plexus via the spinal nerve venous channels (Lasjaunias and 
A., 1990). Although the radicular veins lack valves, they present narrow lumens and take 
an oblique and tortuous course along the dura, allowing them to function as a one-way 
valve. For the extradural system, it is mainly the vertebral venous plexus (VVP) that collect 
blood from the radiculomedullary veins. There are internal and external VVPs. The internal 
VVPs (ventral and dorsal) locate extradurally within the vertebral canal, while the external 
VVPS (also ventral and dorsal) surrounds the vertebral column. After the radicular veins 
5 
drain into the vertebral venous plexus, drainage occurs via the vertebral, deep cervical, and 
jugular veins which eventually lead to the superior vena cana (a large vein carrying 
deoxygenated blood from the upper body into the heart) in the cervical spinal cord region. 
A fundamental feature that distinguishes the vertebral venous system from the systemic 
venous system is the lack of valve allowing for bidirectional and retrograde flow (Groen et 
al., 1997; Tobinick and Vega, 2006). Thus, the venous system functions as a reservoir and 
equilibrates blood flow to and from the brain and other venous systems due to the change 
in posture and pressures. However, the “reflux-regulating” mechanisms of radicular veins 
provide a partial barrier to retrograde flow from the vertebral venous plexus back to the 
intrinsic and extrinsic systems. 
A summary of the blood circulation in the spinal cord is as followed: The left 
ventricle of the heart pumps out the oxygenated blood through ascending aorta into the 
subclavian arteries. The blood passes into the segmental spinal branches through the 
vertebral arteries (VAs). The segmental spinal branches further divide into VSA and DSAs, 
which anastomose with each other forming a radial arterial network. This network supplies 
blood to the spinal cord at the capillary level in two different circuits: the centrifugal 
direction in the central section and centripetal direction in the peripheral section. After the 
oxygen in the blood is used and metabolized to carbon dioxide, the intrinsic venous system 
drains blood from the capillary network into the extrinsic system. After the radicular veins 
drain into the vertebral venous plexus in the extradural system, drainage occurs via the 
vertebral, deep cervical, and jugular veins which lead to the superior vena cana, eventually 
the right atrium of the heart. The low-oxygen blood passes to the right ventricle, and it is 
pumped into the pulmonary circulation, where the blood is replenished with oxygen and 
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removal of carbon dioxide. Oxygenated blood then returns to the left atrium and passes 
into the left ventricle, waiting for the next circulation cycle. 
 
Blood-CNS barrier 
Blood-CNS barrier (BCB) is a term used to describe the unique properties of the 
microvasculature existing at all levels of the CNS, including the blood-brain barrier (BBB) 
and blood-spinal cord barrier (BSCB). Unlike the peripheral system, blood vessels in the 
CNS are continuous nonfenestrated vessels made of endothelial cells (EC), with a complete 
basement membrane (BM) and lacking fenestra (pores) in their plasma membrane. These 
structural features provide tight restriction of exchange between the blood and CNS, which 
maintains proper neuronal function, as well as protection from outside insults, including 
toxins, pathogens, inflammation, injury and disease (Daneman, 2012, Zlokovic, 2008).  
The cellular components of BCB are ECs and mural cells. The barrier also highly 
interacts with astrocytes, neurons, and immune cells to manifest its functions.  
 
Endothelial cells (EC) 
ECs are simple squamous cells derived from the mesoderm that form a single cell layer 
lining the walls of blood vessels. Unlike ECs in peripheral tissues, CNS ECs possess two 
unique physical barrier properties, including tight paracellular flux regulated by tight 
junctions (TJ) and extremely low rates of transcytosis (Brightman and Reese, 1969, Reese 
and Karnovsky, 1967, Westergaard and Brightman, 1973, Coomber and Stewart, 1985). 
Transcytosis transports various macromolecules across the interior of a cell in the form of 
receptor-mediated vesicles. The extremely low rates of this transcellular movement of 
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solutes indicate a much tighter barrier restriction compared to the peripheral tissue. In 
addition, ECs also present a few molecular barrier properties: efflux transporters (Loscher 
and Potschka, 2005), highly specific nutrient transporters (Mittapalli et al., 2010), high 
number of mitochondria for ATP generation supporting ion transportation (Oldendorf et 
al., 1977), and low level of leukocyte adhesion molecules (LAM) (Aird, 2007, Sohet and 
Daneman, 2013). Altogether, these features empower ECs to regulate the homeostasis 
tightly in the CNS. 
 
Pericytes 
There are two types of mural cells involved: vascular smooth muscle cells (SMC) and 
pericytes. Vascular SMCs typically encircle the large vessels such as arteries, whereas the 
pericytes provide high coverage on the endothelial cell layer of all vascular capillaries and 
post-capillary venules (Shepro and Morel, 1993). Pericytes sit on the abluminal surface of 
the microvascular endothelial tube, and are embedded in the vascular BM (Sims, 1986). 
The contractile proteins expressed in pericytes allow their regulation of the capillary 
diameter (Peppiatt et al., 2006, Hall et al., 2014). Previous studies have identified 
regulatory roles of pericytes in the following aspects: angiogenesis; deposition of 
extracellular matrix proteins; wound healing; immune cell infiltration; blood flow in 
response to the neural activity (Armulik et al., 2011). The pericytes are also reported as the 
multipotent stem cells of the CNS (Armulik et al., 2011). One major challenge to study 
these pericytes is lacking specific markers. Currently, a combination of PDGFR-beta and 
NG2 is widely accepted in the field to identify pericytes (Armulik et al., 2011). Uncovering 
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of a more specific marker could unveil the answer to whether different subsets of pericytes 
possess different functions. 
 
Basement Membrane 
The basement membrane (BM) is comprised of type IV collagens, laminin, nidogen, 
heparin sulfate proteoglycans, and other glycoproteins (Sorokin, 2010). There are two 
layers of BM: the inner layer that mainly consists of laminin α4 and α5, secreted by 
neighboring ECs and pericytes; the outer parenchymal layer that comprises of laminin α1 
and α2, produced by astrocytic processes extending onto the vasculature (Sorokin, 2010, 
Del Zoppo et al., 2006). Functionally, BM provides an anchor for signaling processes at 
the level of the vasculature; it also serves as another barrier to cells and molecules before 
entering the neural tissue. Matrix matalloproteinases (MMPs) often disrupt the BM that 
leads to BBB dysfunction and leukocyte infiltration in different neurological disorders 
(Daneman and Prat, 2015). 
 
Astrocytes 
Astrocytes extend their polarized processes to encircle either neuronal processes or blood 
vessels (Abbott et al., 2006). Astrocytes provide a cellular link between the neuronal 
circuitry and blood vessels, called neurovascular coupling. This neurovascular coupling 
allows astrocytes to relay signals that regulate blood flow in response to neuronal activity 
(Gordon et al., 2011, Attwell et al., 2010). Astrocytes take part in regulating the 
contraction/dilation of the blood vessels via vascular smooth muscle cells or pericytes 
depending on the vessel types. Rodent embryo studies suggest that astrocytes do not play 
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a role in the initial induction phase of the BBB (Daneman et al., 2010). However, astrocytes 
modulate and maintain the BBB once formed. Previous studies have shown that purified 
astrocytes were able to induce barrier properties in non-CNS blood vessels during in vivo 
transplantation (Janzer and Raff, 1987). In addition, astrocytes could again induce barrier 
properties in ECs of a co-culture system in vitro (Abbott et al., 2006). At the molecular 
level, the endfeet of astrocytes contain a discrete array of proteins, including dystrophin, 
dystroglycan, and aquaporin-4 (AQP-4). The dystrophin-dystroglycan complex helps the 
endfeet cytoskeleton linking to the BM by binding agrin (Noell et al., 2011, Wolburg et al., 
2011). This linkage coordinates AQP-4 into orthogonal arrays of particles, which is critical 
for regulating water homeostasis. 
 
Immune Cells 
Perivascular macrophages and resident microglia are two types of immune cells involved 
in the surveillance at the blood-CNS barrier. Perivascular macrophages are blood-borne 
monocyte lineage cells, which are able to cross the BBB and be 80% replenished every 
three months (Unger et al., 1993, Vass et al., 1993, Williams et al., 2001). The macrophages 
reside on the abluminal surface of the blood vessels facing toward the CNS parenchymal 
tissue, named the “Virchow-Robin” space (Polfliet et al., 2001, Hickey and Kimura, 1988). 
They are at the first line of immune defense system by phagocytosing cellular debris. 
Microglia are resident CNS immune cells in the parenchyma, which derived from the 
progenitor cells in the yolk sac and entered the brain during embryonic development 
(Ginhoux et al., 2010). Microglia regulate neuronal development, innate immune response, 
wound healing, and they can act as antigen-presenting cells in adaptive immunity (Streit et 
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al., 2005, Ajami et al., 2007). Additionally, there are also other blood-borne immune cell 
populations, such as neutrophils, T cells, and macrophages. During cases of injury, 
infection or disease, these cells become activated and alter the BBB properties by releasing 
ROS to increase vascular permeability (Hudson et al., 2005, Persidsky et al., 1999). It still 
requires further studies to identify the mechanism of both BBB and immune cells becoming 
“activated” under different neurological conditions.  
 
BCB Functional Properties 
These unique barrier properties alow BBB to serve several important functions. First its 
tight restriction protects the CNS from 'foreign substances' which may insult the brain and 
spinal cord. Secondly, BBB compartmentalizes the CNS from peripheral tissue so that the 
CNS would not receive the 'crosstalk' effects of neurotransmitters and hormones that target 
the peripheral system; so similar agents can be applied to two systems for different 
purposes (Abbott et al., 2006). Thirdly, BBB tightly regulates the homeostasis of the 
microenvironment by restricting ion transportation and maintains the fluid balance between 
the blood and the CNS via different ion transporters and channels for proper neuronal 
functions. Additionally, the restriction avoids interference with synaptic transmission 
caused by fluctuations in ionic compositions that can occur after a meal or exercise.  
 
Differences between BBB and BSCB 
Previous studies reported elevated permeability in BSCB compared to BBB, suggesting 
there may be a region-specific difference (Prockop et al., 1995, Pan et al., 1997, Daniel et 
al., 1981). Although there are slight variances between the two structures, BSCB is often 
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considered as the extension of the barrier from the brain to the spinal cord and shares 
similar structures and functions with BBB.  
Besides a blunt trauma like SCI, disruption of the BSCB is also observed in many 
different spinal cord diseases, including spinal cord ischemia (Jacobs et al., 1992), multiple 
sclerosis (MS) (Schellenberg et al., 2007), posttraumatic syringomyelia (Hemley et al., 
2009), amyotrphoic lateral sclerosis (ALS) (Garbuzova-Davis et al., 2007), radiation 
injury(Li et al., 2004), and neuropathic pain (Bartanusz et al., 2011, Beggs et al., 2010). In 
general, BSCB dysfunction can lead to ion dysregulation, altered signaling homeostasis, as 
well as the infiltration of immune cells and molecules into the CNS, processes that lead to 
neuronal dysfunction and degeneration (Bartanusz et al., 2011). 
 
Subsequent vascular and inflammatory responses to SCI 
The primary physical insult inflicted on the spinal cord leads to a subsequent 
temporospatial profile of secondary damages, which usually lasts for months and years 
since the initiation of the trauma. It is widely accepted that vascular disruption is one of 
the early consequences and hallmark of acute SCI (Benton et al., 2009b). During the first 
hour of injury, scientists have found signs of vascular disruption in the injury epicenter 
(Dohrmann and Allen, 1975). The initial vascular damage often results in hemorrhage, 
which is mainly located in the gray matter (Tator and Koyanagi, 1997). The blood 
undergoes hemolysis and the lysed product of red blood cells infiltrates into the 
perivascular space, which is rather toxic to the parenchyma and eventually leads to 
neuronal and axonal damage (Asano, 1980). The infiltration of neutrophils releases 
proteolytic enzymes, which also causes injury to local cells. At 24 hour post-injury, there 
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is evidence of vasospasm (Anthes et al., 1996), hypo-vascularity (Benton et al., 2008, Loy 
et al., 2002), decreased blood flow in the injury epicenter (Rivlin and Tator, 1978). 
Reduction of blood flow leads to ischemic damage to the spinal cord, primarily in the white 
matter (Tator and Koyanagi, 1997). These pathological vascular changes trigger a multi-
factorial event which is facilitated by inflammatory cytokines and chemokines, eventually 
lead to cell death and tissue destruction via various mechanisms, including glutamate 
excitotoxicity, oxidative stress, oxygen deprivation, and necrosis (Alizadeh et al., 2019). 
In addition, vascular injury plays a key role in initiating secondary inflammatory 
responses via activation of CNS innate immune cells (microglia and astrocytes) and 
infiltrating leukocytes (neutrophils, monocyte, macrophages, and lymphocytes) (Mautes et 
al., 2000, Anwar et al., 2016). The initial vascular disruption leads to immediate response 
from endothelial cells (Benton et al., 2009b), loss of astrocytic investment (Whetstone et 
al., 2003), regression of pericytes (Benton et al., 2008), perivascular localization of 
infiltrating inflammatory cells (Popovich and Jones, 2003), activation of microglia (Li et 
al., 2013), astrocytes (Hawkins and Davis, 2005), subsequent loss of oligodendrocytes 
(Crowe et al., 1997, Liu et al., 1997), neurons and axons (Daneman et al., 2010). 
Specifically, microglia become activated after detecting cues of cellular or tissue damage 
in the CNS, including a pathway via extravasation of serum protein fibrinogen (Davalos et 
al., 2012). Upon activation, microglia undergoes hypertrophic morphological and 
functional transformation into two polarized states: the M1 (classically activated) pro-
inflammatory phenotype and M2 (alternatively activated) anti-inflammatory phenotype 
(Witcher et al., 2015, Durafourt et al., 2012). The activated M1 phenotype initiates the 
inflammatory cascades which go through multiple pathophysiological signaling pathways, 
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including cytokines (TNF-α, IL-1β, IL-6) (Rothwell et al., 1997, Pan et al., 2002, Pineau 
and Lacroix, 2007), chemokines (Mantovani et al., 2004), nitric oxide (Merrill et al., 1993, 
Matsui et al., 2010), reactive oxygen species (ROS) (Barger et al., 2007), glutamate (Barger 
et al., 2007), and proteases (Shields et al., 2000). The M2 phenotype releases anti-
inflammatory cytokines (IL-4, IL-10, IL-13) (Witcher et al., 2015, Durafourt et al., 2012). 
Taken together, these two distinct microglia phenotypes and many intermediate states of 
cells participate in the regulation of the inflammatory response and reorganization of the 
homeostatic microenvironment. Astrocytes and macrophages also undergo polarization of 
pro- and anti-inflammatory states, which is similar to microglia (Cherry et al., 2014). 
Additionally, activation of microglia and macrophages leads to not only clearance of 
cellular and molecular debris, but also loss of oligodendrocytes, axon demyelination, and 
neuronal apoptosis (Merrill et al., 1993, Shuman et al., 1997, McTigue and Tripathi, 2008). 
This secondary wave of pathological damages has been considered to be a primary cause 
leading to functional deficits after SCI (Casella et al., 2002, Loy et al., 2002). 
 
Current limitation/challenge to study vascular injury 
There has been interest in studying vascular injuries following SCI for decades. However, 
one major challenge is the technical limitations. Traditional techniques are largely 
restricted to the investigation of vascular structural changes in post-mortem samples 
(Figley et al., 2014, Loy et al., 2002). For example, vascular corrosion casts were frequently 
used to obtain the structural information of the vasculature in various animal models 
(Koyanagi et al., 1993a, Mazensky et al., 2015, Naka et al., 1987). In brief, a three-
dimensional mold of the blood vessel network was acquired by filling the perfused 
14 
vasculature with polyester resin and dissolving surrounding tissues, followed by inspection 
of scanning electron microscopy (SEM). Although this technique showcased vascular 
organization, it cannot provide dynamic vascular changes at pre- and post-injury. In 
addition, this technique often encounters problems of insufficient perfusion in traumatic 
tissues, therefore, it cannot differentiate different types of morphological changes in blood 
vessels, such as loss of vasculature, occlusion, and rupture. Other techniques, including 
hydrogen clearance (Kobrine et al., 1974), autoradiography (Rivlin and Tator, 1978), and 
silicone rubber microangiography (Tator and Koyanagi, 1997), have also encountered 
difficulties in observing dynamic vascular changes. In addition, all techniques mentioned 
above require extensive time for processing the post-mortem samples, which in turn 
increases the difficulty of experimental operations.  
Although laser doppler flowmetry (LDF) provides real-time measurement of gross 
regional blood flow in vivo, the major disadvantage of this method is the high variable 
results, affected by artifacts such as the probe placement and environmental factors (Tei et 
al., 2005). Besides a gross readout of the blood flow, this technique cannot provide 
information on morphological and physiological changes in spinal cord vasculature. A 
reliable and accurate method is still in urgent need to study vascular injury following SCI 
on living animals. 
 
Current knowledge on the expansion of secondary injury 
After the initial mechanical impact, the following secondary injury is held accountable to 
the continuing enlargement of lesion size from the initial injury for a long time after SCI 
(Liu and Xu, 2012). Previous studies indicate the lesion starts from the injury epicenter and 
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expands rostrocaudally over time leading to the death of initially viable axons and cells 
resulting in deleterious functional loss, which became the most acceptable view of a 
“spindle-like” pattern in secondary injury progression (Tator and Fehlings, 1991, Onifer et 
al., 2007a). This “spindle-like” pattern considers the initial responses of all cellular 
components, including vasculature and neurons, are restricted within the mechanical 
impact site. However, the role and underlying mechanisms of early vascular disruption in 
progressive degeneration after SCI remain elusive.  
 
The knowledge gaps 
Several key questions remain to elucidate the vascular mechanisms contributing to SCI. 
First, to my knowledge there was no study available on in vivo vascular changes after acute 
SCI. Second, it is unknown whether SCI triggers immediate vascular responses in areas 
beyond the initial injury. Third, it is also unidentified whether the vascular injury precedes 
or is simultaneous with other cellular responses in the adjacent areas next to the initial 
injury. The last question I asked is whether a therapeutic strategy targeting acute vascular 
leakage could lead to histological and functional recoveries. 
To address the first question, I developed a “duo-color” method using two-photon 
laser scanning microscopy (TPLSM) in vivo to visualize spinal cord vasculature. A 
sequential injection of two different colored tracers allows me to monitor changes in the 
same vessels before and after SCI. A single-color tracer will leak outside the blood vessel 
after the trauma to indicate the range of extravasation, but it can no longer trace the pattern 
of blood vessels. The following second color tracer can capture the post-trauma blood 
vessels within a period of time after injection. This imaging tool allows me to assess 
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changes in both vessel diameter and permeability. Thus, I have successfully monitored 
various vascular changes in vivo in an SCI model for the first time, allowing me to identify 
potential vascular targets following SCI. 
To address the second and third questions, I designed experiments to determine 
region-specific vascular changes at the injury epicenter (C7), the adjacent (C6) and the 
remote (C5) cord regions, using my in vivo duo-color approach and histological analyses. 
My results showed that vascular injury, including vasodilation and increased vascular 
permeability, occurred in areas beyond the initial injury site, and in a “transitional zone” 
vascular injury precedes other cellular changes. In conclusion, I found a time window 
between vascular injury and other secondary degeneration in the transitional zone. 
To address the last question, I designed a three-part experiment to examine the 
effect of a nanoparticle, FA-GC, on targeting vascular leakage following injury. My results 
showed that FA-GC effectively reduced vascular leakage, resulted in acute neuroprotection 
and partial functional recovery. Thus, I believe that targeting vascular leakage is a potential 
therapeutic strategy, as well as a proof of concept that initial vascular damages are involved 
in subsequent secondary injuries. 
In summary, this thesis highlighted a new role of early vascular injury on 
progressive secondary degeneration following SCI and tested a new therapeutic strategy 





CHAPTER 2  
DEVELOPING A NOVEL IN VIVO IMAGING METHOD TO MONITOR DYNAMIC 
VASCULAR DAMAGES FOLLOWING ACUTE SPINAL CORD INJURY 
 
Hypothesis  
A newly established in vivo imaging technique enables me to detect a temporospatial 
profile of dynamic spinal vascular changes, including blood vessel diameter and vascular 
permeability, in a contusive spinal cord injury rat model. 
 
Introduction 
In order of precedence, SCI is categorized into primary and secondary injury phases. The 
primary injury phase often refers to the direct mechanical impact which leads to 
hemorrhage and necrosis at the site of injury within minutes after SCI (Dumont et al., 
2001). In the following hours and days, the range of damaged tissue is expanded due to a 
cascade of secondary injuries, including inflammation, cell apoptosis, and demyelination 
of remaining axons (Beattie et al., 2000, Liu et al., 2006, Wu and Xu, 2016, Li et al., 2016). 
Vascular disruption occurs immediately after SCI, indicated by the evident sign of 
hemorrhage (Kulkarni et al., 1987, Tator and Koyanagi, 1997). It is of great potential to 
target these acute vascular damages for neuroprotection, but a better knowledge of spinal 
vascular pathophysiology following SCI is vital.  
Quite a number of techniques have been applied on spinal vascular studies since 
1970s, such as hydrogen clearance (Kobrine et al., 1974), autoradiography (Rivlin and 
Tator, 1978), microangiogram (Tator and Koyanagi, 1997), vascular corrosion casts 
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(Koyanagi et al., 1993b), electron microscopy (Anthes et al., 1996), and 
immunohistochemistry (Noble and Wrathall, 1989a, Maikos and Shreiber, 2007). These 
methods indeed broaden my insights on the anatomy of the spinal vascular system, but 
their applications restricted to postmortem samples reveal a few limitations. All above-
mentioned procedures are time-consuming, and the vascular structures receive various 
degrees of distortion depending on specific chemical steps during the processes. Most 
importantly, none of them can capture the morphological changes in these injured vessels 
accurately due to the technical limitations. For example, vascular corrosion casts often 
cannot generate the exact vascular structures due to either insufficient perfusion of the 
micro-vessels or excessive aggregation of the resin leaking outside the ruptured vessels. 
Altogether, these techniques are unable to monitor dynamic vascular changes following 
SCI.  
There are some available imaging options providing real-time monitoring on living 
animals. Laser Doppler Flowmetry (LDF) provides a continuous measurement of 
microvascular blood perfusion in the spinal cord (Tei et al., 2005). Although LDF presents 
a great advantage with the noninvasive nature, its high sensitivity to all types of movements 
results in poor data reproducibility (Fagrell and Nilsson, 1995). In addition, LDF cannot 
provide information in vascular morphology. Another noninvasive method is Dynamic 
Contrast-enhanced MRI (DCE-MRI), but the required infrastructure is costly and DCE-
MRI-related agents often present low sensitivity to vascular changes (Cohen et al., 2009, 
Yan et al., 2017). In order to study the vascular pathophysiology, a technique that can 
simultaneously provide in vivo changes and high-resolution images is highly required. 
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The in vivo imaging using 2-photon laser scanning microscopy (2P-LSM) is a great 
option for spinal vascular imaging given that it has been used for vascular dynamic studies 
in the cortex (Drew et al., 2011, Schaffer et al., 2006, Kim et al., 2012). In a spinal cord 
hemisection model, Tang et al. detected blood flow fluctuation at the periphery of the lesion 
site (Tang et al., 2015). However, it is not amenable to spinal vascular imaging because it 
requires technical optimization to adapt imaging at traumatic tissue areas. There are three 
main challenges. First, the installation of the imaging window allows repetitive imaging at 
the lesion epicenter pre- and post-injury. Second, SCI has technical limitations that make 
post-injury imaging difficult. Last, the stabilization of the spinal cord during imaging is 
critical for stable imaging but often affected by breathing and pulsation.  
To overcome these difficulties, I first successfully established a novel in vivo 
method to visualize vascular dynamics. By sequentially injecting two different fluorescein-
conjugated dextran tracers intravenously, this tool can provide a temporospatial profile in 
dynamic vascular changes, such as blood vessel diameter and permeability, before and after 
a contusive SCI model. 
 
Step-by-step procedure 
1. Animals and Surgical Preparation 
Adult female Sprague-Dawley (SD) rats (180-220 gram, Harlan) were housed in controlled 
conditions with a 12:12 light: dark cycle, and free access to food and water ad libitum. To 
prepare for surgery, the rats were anesthetized with an intraperitoneal injection of ketamine 
(87.7mg/kg)/xylazine (12.3mg/kg) and confirmed with no response from a toe pinch 
stimulus. For the purpose of animal welfare, the animals also received a subcutaneous 
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injection of Buprenorphine (0.01-0.05mg/kg) and Carprofen (5mg/kg) for analgesic and 
anti-inflammatory effects. Prior to surgery, both the cervical spine area (back side) and 
neck (breast side) were shaved, and the skin areas were swabbed with betadine and 70% 
alcohol. It is critical to maintain the body temperature of the rats by placing them on the 
heating pad. All surgical and animal handling procedures were performed as approved 
under the Guide for the Care and Use of Laboratory Animals (National Research Council) 
and the Guidelines of the Indiana University School of Medicine Institutional Animal Care 
and Use Committee. 
2. External Jugular Vein Catheterization 
On the breast side of the rat, a vertical incision was made on the skin near the right side of 
the clavicle to expose the external jugular vein, which is at the superficial layer of the neck 
amenable to visual identification. The landmark of the vein was the pulse point in the 
triangular area connected by three anatomical points: caudal ramus of the right mandible, 
greater tubercle of humerus and manubrium (Fig. 2.1A). After separating from adjacent 
muscles and connective tissues, the external jugular vein was first tied at the distal end to 
the heart (Fig. 2.1C) (Thrivikraman et al., 2002). At the proximal end, the vessel was 
incised with a small opening and inserted a specialized catheter (Fig. 2.1B) connected to a 
saline-filled syringe. The extra needle piece welded onto the specialized catheter was to 
secure the catheter placement from slipping out of the vein. The proper function of the 
catheter was confirmed by blood aspiration and successful subsequent flushing with saline. 





Figure 2.1. Jugular vein catheterization and spine stabilization.  
(A) A schematic drawing for locating the external jugular vein. (B) The specialized catheter 
made from a 21-gauge needle. The tip was ground flat and welded with a piece of 2 
millimeter tip cut off from another 21-gauge needle. (C) A schematic diagram of 
catheterization. The distal end is ligated first, followed by proximal catheter stabilization, 
ending with fastening the needle along with the vessel (vessel ligation, blue arrowheads). 
(D) An image of the modified spine stabilizer. A C5-C7 window prior to laminectomy (E) 
and after laminectomy and contusive SCI (F) is displayed.  
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3. Spine Stabilization and C5-C7 Laminectomy 
This step is adapted from previous protocols (Walker et al., 2015, Anderson et al., 2009, 
Krishna et al., 2013, Lepore, 2011). In brief, a pair of customized spine stabilizers were 
utilized to fix the 5th to 7th cervical vertebrae and a C5-C7 laminectomy exposed the cord 
area with intact dura mater. Prior to the next step, a small piece of saline-soaked gelfoam 
was placed on top of the exposed cord to maintain moisture (Fig. 2.2). 
4. Installation of Two-photon (2P) Imaging Window  
To maximize the prevention of bleeding, small pieces of gelfoam were carefully placed 
into the gaps among spinal cord, muscles and vertebral bones, followed by sealing with 
tissue adhesive glue. After completely dry, 4% agar solution (dissolved in saline, preheated 
and cool down to room temperature) was added around the rim of the window to build a 
wall which quickly solidified (Fig. 2.2E). Then the imaging window is ready for the next 
step. 
5. Baseline Imaging  
The first fluorescent agent was prepared in saline with Rhodamine B isothiocyanate-
Dextran (Rho-Dextran, 4 mg/ml, ~70 kDa in average molecular weight, λmax. ∼543 nm). A 
dosage of 0.5 ml was filled in a 1 ml sterile syringe and connected to the installed catheter. 
The animals were then transferred to a two-photon laser-scanning microscope (TPLSM, 
Prairie Technologies, Middleton, WI). The area of exposed C5-C7 spinal cord segments 
was focused under bright-field. For baseline imaging, a bright-field image of the superficial 
spinal blood vessels was first captured at 4x magnification (NA 0.1; Olympus, Shinjuku, 
Tokyo, Japan). This image served as a map of landmarks to track individual blood vessels. 
The Rho-Dextran was then slowly administered through the external jugular vein catheter.  
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Figure 2.2. Schematic diagram of optic window installation step-by-step.  
(A) Step 1: expose the vertebra by cutting skin and muscle along the midline. (B) Step 2: 
spine stabilization. (C) Step 3: laminectomy. (D) Step 4: maintain the moisture of the spinal 
cord by placing a piece of saline-soaked gelfoam. (E) Step 5: seal the gaps with sterile 
gelfoam and vetbond. After drying, a layer of agar wall is built on the edge of the window. 
(F) Step 6: when ready for imaging, remove the gelfoam and place immersion fluid inside 
2P imaging window.  
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After switching to laser scanning mode, the proper 2P laser excitation wavelength, power 
and red fluorescent channel were selected (Fig. 2.3E). A series of Z-stack images with the 
thickness of 200-400 µm were obtained across C5-C7 dorsal spinal tissue at 10x 
magnification (NA 0.30; Olympus). In addition, the line-scan images were generated by 
fast scanning along a defined path on individual blood vessels. Within the view of each 
spinal cord segments, 5-10 blood vessels were captured. Each imaging session usually 
takes 30 to 45 minutes to complete starting from the injection of the tracer. The animals 
were placed on a heating pad during the whole process. 
6. Contusive Spinal Cord Injury at C7 
Spinal cord injury was performed using a Louisville Injury System Apparatus (LISA) 
device based on a previously established protocol (Zhang et al., 2008, Wu et al., 2017). 
LISA was calibrated every time prior to performing injury. Briefly, the animals received a 
midline contusive SCI at the 7th cervical spinal cord segment with an adjusted tissue 
displacement of 0.800mm. After the injury, the exposed dura mater was left with another 
piece of saline-soaked gelfoam on top to stay moisturized. The animal was placed back on 
a heating pad and appropriate anesthesia was given when necessary. 
7. Post-injury Imaging 
This step is similar to the previous baseline imaging step except that a second fluorescent 
dye, Fluorescein isothiocyanate-Dextran (FlTC-Dextran, 4 mg/ml, 0.5 ml, ~70 kDa in 
average molecular weight, λmax. ∼492 nm), was slowly injected before post-injury imaging. 
After locating the same vessels, both red and green fluorescent channels were selected to 
capture both blood extravasation and post-injury blood vessels labeled by Rho-Dextran and 
FITC-dextran (Fig. 2.3D, G). Another series of Z-stack images were obtained, and line-   
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Figure 2.3. The in vivo duo-color method procedure step-by-step.  
The whole procedure consists of 5 steps (A). Following Step 1 and Step 2, a pair of dextran 
tracers with a size of approximate 70 KDa are injected in sequence to label the spinal cord 
vasculature before (B and C) and after contusive SCI (D). (E)-(G) representative 2P images 
display the spinal cord vasculature at Step 3 through Step 5. White arrows point to first-
wave red dye leaking areas (F and G), turquoise arrowheads display second-wave green 
dye leakage (G). Scale bar = 50 μm.   
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scan images were generated by fast scanning along a defined path on individual blood 
vessels.  
 
Data analysis and representative results 
The measured parameters are vessel diameter, vascular permeability, and RBC velocity. 
The first two parameters were analyzed via ImageJ. The single image files were first 
calibrated true to scale (Fig. 2.4A-C). For vessel diameter, a line is drawn perpendicular to 
the long axis of the vessel segment to measure the diameter. Repeat 3 times across the 
vessel to acquire the average value (Fig. 2.4D1-2 & E1-2). An example is presented here that 
the diameter of the vessel has been increased significantly in response to the injury at 30 
minutes after SCI (Fig. 2.4F). For vascular permeability, a 200 μm line is drawn inside and 
outside the vessel to measure the fluorescence integrated density. The vascular 
permeability is calculated as the ratio of the outside value divided by the inside value (Fig. 
2.5). A higher ratio means increased vascular permeability. The RBC velocity was 
quantified based on the line-scan images using MATLAB-based software adapted from a 
previously established protocol (Kim et al., 2012).  In brief, each dark streak stands for the 
moving path of individual red blood cell (RBC) since the dextran dyes do not stain the 
RBCs. The speed is determined by the traveled distance of the RBC over time, shown as 
Δx / Δt (Fig. 2.6A). The final RBC velocity along the scan line is determined from average 
peak values over time (Fig. 2.6B-C, middle dashed line). In addition, the observed vessels 
can be categorized into arteries and veins based on the following criteria: blood vessel 
morphology, blood flow velocity, and vessel diameter (Table 2.1). All required materials 
to complete this procedure are included in the following table (Table 2.2).  
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Figure 2.4. Acquisition and quantification of spinal vessel diameters.  
Following preparation, single image files are acquired under 2P microscopy, along with 
XML files of calibrated values (B). (A) The equation displays the calculation of "pixel per 
micron" based on optical zoom values. After calibration in ImageJ (C), vessel diameters 
are measured at 3 points across the longitudinal axis before (D1) and after (E1) injury. (D2) 
and (E2) display the measured values. (F) Quantification of vessel diameters at baseline 
and 30 min post-injury. Scale bar = 50 μm. Data are shown as mean ± SD, ***p<0.0001, 
two-tailed paired t test.  
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Figure 2.5. Measurement of vascular permeability.  
(A) Before and after SCI, a probe of is drawn both inside and outside the vessel to measure 
the fluorescence integrated density of the first Rho-dextran dye. (B) The vascular 
permeability is calculated as the ratio of the outside value divided by the inside value.   
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Figure 2.6. Acquisition and quantification of spinal vessel velocity.  
Line-scan image files are acquired under 2P microscopy to calculate single vessel 
velocities. (A) An example of a selected vessel and method to assess blood vessel RBC 
velocity. (B) An arterial example of a line-scan image and corresponding plot file for 
calculation of velocity, as well as an example of a vein (C). Y-axis indicates speed and x-
axis shows time.  
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Table 2.1. Criteria for identifying vessel types 
 
  Artery Vein 
Morphology Straight, smooth, thick vessel wall Branches, rough edges 
Blood Flow 
Velocity 
Fast Slow but varies 
Diameter 30-80 µm 100-250 µm 
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Table 2.2. List of materials for in vivo duo-color method 
 








Betadine Surgical Scrub 
Fisher 

















Dukal Gauze Sponges  
Fisher 
Scientific 22-415-490 Skin sterilization 
Decon Ethanol 200 Proof 
Fisher 
Scientific 04-355-450 Skin sterilization 
Artificial Tears Eye 
Ointment 
Webster 




Scientific  1006015  
Heparin sodium salt from 
porcine intestinal mucosa Sigma-Aldrich H3149 
187 USP per ml, 
prevention of blot 
clotting 
Rhodamine B 
isothiocyanate–Dextran Sigma-Aldrich R9379 
Average mol wt 
70kDa 
Fluorescein 
isothiocyanate–dextran Sigma-Aldrich 46945 





for sterilizing surgery 
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Care Products 1469SB Tissue adhesive Glue 
Gelfoam Henry Schein 9083300 Stop bleeding 
Noyes Spring Scissors F.S.T 15013-12  
Fine Forceps- Dumont 
#5 F.S.T 11254-20  
Rongeur 
Fine Science 
Tools 16021-14 laminectomy 
Surgical Retractor 
Fine Science 







Scalpel Blade #15 Royal-Tek BS2982 skin cut 




500260 Can be from any 
vendor 
3-0 vicryl sutures Ethicon J393H 





Can be from any 
vendor 
21 gauge needle BD 
305165 
Can be from any 
vendor 
Agar Sigma-Aldrich A1296 













Contact Y. Ping 
Zhang for details. 
(yipingzhang50@gm
ail.com) 










 Two-photon imaging 
software 
ImageJ  
 Image analysis 
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Lacking a stable imaging model is one major challenge to monitor vascular changes 
following SCI successfully. Currently available measures limit their applications on 
postmortem samples, which only provide a snapshot of the vascular structural changes. 
Using 2P-LSM, my innovative duo-color imaging method allows continuous observation 
of vascular changes in living animals. In the same animal, several vascular parameters can 
be measured simultaneously, such as RBC velocity, vessel diameter, and vascular 
permeability. The design of this sequential two-dye injection is unique from other intravital 
imaging methods. At a specific post-injury timepoint, while the immediate delivered 
second dye remains in the vessel and captures vascular structures, the leakage of the 
previous tracer can indicate the change of vascular permeability in response to the injury. 
Additionally, this method is flexible to generate a temporospatial profile of vascular 
changes at the acute phase of SCI.  
There are several key steps in this method that are worth noting. First, ensuring a 
complete stabilization of the spinal cord is essential to guarantee every successful time-
lapse imaging. Due to the location of the spinal imaging window, motion artifacts occur 
due to breathing and pulsation. These motion artifacts can be greatly reduced by raising 
the spinal vertebral slightly using the modified stabilizing spinal clamps (Fig. 2.1D-F, 
2.2B).  Inspection and readjustment of the spinal clamps are needed prior to each imaging 
session if stabilization fails. Second, it is critical to prevent blood seeping into the imaging 
window from peripheral tissues (bone, muscles, and skin). An effective measure to stop 
bleeding is to apply gelfoam to all the gaps between bones and muscles followed by a seal 
using tissue adhesive glue. Third, the choice of the fluorescein-conjugated dextran tracers 
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is also particular for this application. As one main blood plasma protein, serum albumin 
does not extravasate from the endothelium under physiological conditions. The chosen 
tracers (70 kDa) have slightly higher molecular weight than serum albumin (66 kDa), so 
the endothelium is also impermeable to the dyes under normal conditions (Egawa et al., 
2013). In response to SCI, the endothelium is disrupted and becomes permeable to these 
tracers. Their leakage in the parenchyma leads to elevated fluorescent intensity outside of 
the blood vessel (Fig. 2.3F-G, arrows). Lastly, the delivery route via external jugular vein 
is chosen for both flexible accessibility and a route of potential drug administration. 
It is worthwhile to address some caveats regarding this novel vascular imaging 
method. To begin with, this technique is customized to measure vascular changes at a pair 
of pre- and post-injury time points in the studies mentioned in the next few chapters. Given 
more available fluorescent colors and imaging channels, it is feasible to investigate 
multiple time points. Furthermore, several previous chronic intravital imaging studies 
installed a glass imaging chamber, which made it difficult to align baseline and post-injury 
changes on the same vessels (Davalos et al., 2008, Davalos and Akassoglou, 2012, Farrar 
et al., 2012, Evans et al., 2014, Tang et al., 2015). My imaging window is a coverless design 
suitable for the demand of pre- and post-injury imaging at the acute phase of SCI. For long-
term observation, the imaging window would require further optimization. A technical 
improvement such as detachable glass coverslip or imaging chamber may solve the 
problem for chronic imaging. Finally, the current approach solely relies on vascular 
morphology and blood flow rate to distinguish vessel types (Table 2.1). The method may 
be optimized to use a specific tracer which recognizes the arteries (Shen et al., 2012). 
Improvement on identifying different blood vessel types, including morphological features 
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and functions, can help to elucidate the systemic changes of the entire vascular network. 
Additionally, I only used female SD rats for this study because my pilot study showed male 
rats have difficulty to maintain the required sedated state under the same dosage of 
anesthetic drug, ketamine, compared to female counterparts. This may be due to the sex 
differences in ketamine pharmacokinetics in rats and male rats are likely to have a greater 
ability to produce metabolite of ketamine (Waterman and Livingston, 1978, Saland and 
Kabbaj, 2018). 
This imaging technique has various applications besides traumatic models. It can 
be also applied to studies related to neurodegenerative diseases such as amyotrophic lateral 
sclerosis (ALS) and multiple schlerosis (MS) to detect abnormalities in Blood-CNS barrier. 
In addition, the method can be combined with transgenic animal models with specific 
labeling of endothelial cells or astrocytes to study the neurovascular coupling. Lastly, the 
efficacy of potential drugs targeting vascular dysfunction could be tested using this 
imaging technique.  
In the following chapters, this imaging tool will be applied to assess vascular 
dysfunction following a cervical SCI model. In the next chapter, this in vivo duo-color 
method provided a reliable characterization of temporospatial vascular changes following 
SCI. In chapter 4, this method was applied for screening a nanoparticle treatment to reduce 




CHARACTERIZATION OF A TEMPOROSPATIAL PROFILE IN DYNAMIC 
VASCULAR CHANGES CORRELATING WITH DIFFERENT CELLULAR 
CHANGES FOLLOWING A CERVICAL SPINAL CORD INJURY 
 
Hypotheses  
1) A contusive SCI induces a rapid and large-scale vascular disruption beyond the direct 
impact site. 2) At acute phase, a temporospatial profile of vascular changes correlating with 
other cellular pathological changes defined three regions: epicenter (disruption in both 
vasculature and neuronal components), transitional zone (disruption only in the 
vasculature), and remote zone (no changes in both). 3) In the transitional zone, immediate 
vascular changes occur prior to the loss of neuronal components. 
 
Introduction 
The endothelial cells of spinal blood vessels appear to be the first cells to die following 
traumatic SCI (Griffiths et al., 1978, Casella et al., 2006). Ultrastructural studies show 
pathological changes in vasculature minutes after SCI (Goodman et al., 1979, Koyanagi et 
al., 1993a). Unlike an isolated organ, the formation of blood vessels in the spinal cord often 
accompany neurogenesis during early development and integrate into an intricate and 
homeostatic network communicated with other cells in the CNS system that are the first 
line of defense against outside challenges. The microvasculature within the spinal cord is 
composed of an integrated unit consisting of not only the endothelial cells and tight 
junctions, but also pericytes, astrocytes, and neurons (Benton et al., 2009a). The 
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perturbation of the vascular network induced by SCI often triggers disruptions at multiple 
levels and a series of cascades simultaneously. Previous studies reported immediate 
vascular events following SCI, including hemorrhage (Noble and Wrathall, 1985), 
vasospasm (Anthes et al., 1996), edema (Sharma et al., 1991, Nesic et al., 2006, Yashon et 
al., 1973), and ischemia (Dolan and Tator, 1982, Sandler and Tator, 1976), as well as the 
breakdown of the blood-spinal cord barrier (BSCB)(Sharma, 2005, Benton et al., 2008). 
Angiogenesis for the reorganization of the vascular network, was also reported as a delayed 
vascular event (Fassbender et al., 2011, Loy et al., 2002, Casella et al., 2002, Benton et al., 
2008). Numerous cases show that perturbation of the anatomical and functional integration 
of the microvasculature can result in neural pathology (Hawkins and Davis, 2005). Since 
the vascular injury is a hallmark of SCI, targeting its disruption may represent a promising 
strategy as the preservation of metabolic support of spinal tissue spared by the primary 
injury should result in the enhanced substrate for functional recovery (Benton et al., 2009a). 
To date, research on vascular injury and repair remains to be a largely underexplored field 
for clearly dissected mechanisms and effective therapeutic treatments.  
To begin with, a comprehensive profile of the vascular dynamic changes following 
SCI is in urgent need for identifying the most important factor(s) contributing to neural 
pathology. In addition, correlating the changes in spinal vasculature and other cellular 
responses to SCI in time and space will reveal more clues of direct or indirect mechanisms 
of progressive neural damage. During the development of in vivo spinal vascular imaging 
technique, my initial study found rapid and large-scale vasodilation and blood protein 
extravasation in the acute phase of SCI. The range of this phenomenon was beyond the 
scope of primary injury brought by the mechanical impact. This finding was not mentioned 
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in the previous understanding of the pathophysiological pattern following SCI. A 
conventional explanation is that the lesion starts from the direct injury site and expands 
rostrocaudally over time leading to the death of initially viable axons and cells resulting in 
a deleterious functional loss (Tator and Fehlings, 1991, Onifer et al., 2007b).  Here I 
hypothesize that at the acute phase of SCI there is a spinal cord region at a “transitional” 
state where vascular disruptions occur, yet no other cellular changes. Thus, the following 
experiments were designed to test the alternative hypothesis. 
To characterize the temporospatial changes of spinal cord vasculature following 
SCI, I conducted the following study using a novel in vivo imaging method to dynamically 
measure changes in vessel diameter, and vascular permeability in a moderate SCI model 
via two-photon laser scanning microscopy (Chen et al., 2017). Combined with 
histopathological analysis, the present study aims to determine whether a regional 
difference exists in the temporal relationship between vascular disruption and neuronal 
pathology, as well as other supporting cells in the CNS. 
 
Materials and methods 
Animals and spinal cord injury model  
Six weeks old female Sprague-Dawley rats (180-220 g, n = 76, Envigo RMS, Inc., 
Indianapolis, IN) were housed with an air filter in an environmentally-controlled facility 
with a 12-hour/12-hour light/dark cycle. The animals had free access to food and water 
throughout the entire study. Prior to surgery, the rats were deeply anesthetized with an 
intraperitoneal injection of ketamine (87.7mg/kg) and xylazine (12.3mg/kg) mixture. 
Depending on the purpose of either in vivo imaging or histological analysis, a laminectomy 
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was performed either at the cervical 5th-7th vertebrae (C5-C7) or C7 only, respectively. For 
SCI, the animals received a mild-to-moderate C7 midline contusive injury (tissue 
displacement = 0.800mm) using a Louisville Injury System Apparatus (LISA) device 
according to my previously established protocol (Zhang et al., 2008). For two-photon in 
vivo imaging, rats received a C5-C7 laminectomy (n = 32) and were grouped for imaging 
at different acute time points following SCI: Sham, 0.5 hour post-injury, 2 hour post-injury 
and 4 hour post-injury groups (n = 8 each group). These animals were terminated after 
imaging.  
For histological analysis, another group of rats received a C7 laminectomy (total n 
= 44) were divided into the same 4 groups (n = 8 each group), with 2 additional groups: 1 
day and 7 day post-injury groups (n = 6 each group). Following injury, the muscles and 
skin were closed with sutures and antibiotic ointment was applied to the wound. The rats 
were given a subcutaneous injection of 5 mL 0.9% saline subcutaneously for hydration and 
placed in temperature-controlled cages to monitor recovery with easy accessibility to water 
and food. The analgesic buprenorphine (0.05-2.0 mg/kg) was subcutaneously delivered 
every 6-12 hours post-surgery for 2 days. Bladder expression was applied three times a 
day. All procedures were approved by the Institutional Animal Care and Use Committee 
of Indiana University School of Medicine and Institutional Biosafety Committee and were 
strictly following the National Institutes of Health (NIH) Guide on humane care and the 





In vivo spinal vascular imaging 
In vivo spinal vascular imaging was performed as previously described (Chen et al., 2017). 
The step-by-step procedure was also provided in chapter 2. In brief, the animals received 
a catheterization via an external jugular vein (EJV) for future tracer injections in the first 
step. The second step is to use a customized device to stabilize 5th to 7th cervical vertebrae 
followed by a laminectomy. After sealing the surrounding muscle-bone field with tissue 
adhesive, a line of 4% agar was built around the edge to form the wall for a two-photon 
imaging window. In the third step of pre-injury imaging, 0.5 mL of Rhodamine B 
isothiocyanate-dextran (Rho-dextran, 70kDa, Sigma-Aldrich, 4 mg/mL, dissolved in 
saline) was injected slowly via the EJV catheter. The rats were then placed under a two-
photon laser-scanning microscope (2P-LSM, Prairie Technologies, Middleton, WI) 
focused on the exposed C5-C7 spinal segments. The same fields were identified and 
imaged at all different time points. At 4x magnification (NA 0.1; Olympus, Shinjuku, 
Tokyo, Japan), a bright-field image of the surface blood vessel pattern was acquired as a 
location map using a charge coupled device (CCD) camera. At 10x magnification (NA 
0.30; Olympus), a series of Z-stack images with the thickness of 200-400 µm was collected 
through dorsal spinal tissue across the C5-C7 spinal cord segments. The fourth step is to 
perform SCI. In the fifth step of post-injury imaging, 0.5 mL of Fluorescein isothiocyanate-
dextran (FITC-dextran, 70kDa, 4 mg/mL, dissolved in saline) was slowly injected. The 
imaging procedure was repeated as performed in the step of pre-injury imaging. For 2P-
LSM parameter settings, excitation was provided by a tunable Maitai Ti:sapphire laser 
(Newport, Mountain View, CA) tuned to 860 nm.  
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Measurement of vessel diameter and vascular permeability in vivo 
The acquired Z-stack images with a depth of 200-400 µm were analyzed via imageJ to 
measure changes in vessel diameter and vascular permeability. The images were first 
calibrated based on both the magnification of the objective and the digital enlargement 
factor recorded during the imaging session. For vessel diameter, a line is drawn 
perpendicular to the long axis of the vessel segment to measure the diameter. The diameter 
of the blood vessel is determined by the average of three measurements across the vessel 
segement. For vascular permeability, a probe of a 200 μm line is drawn both inside and 
outside the vessel to measure the fluorescence integrated density. The vascular 
permeability is calculated as the ratio of the outside value divided by the inside value.  
 
Tissue processing for histological assessments 
For the groups of animals for histological analysis, tissues were collected and processed as 
previously described (Liu et al., 2006). At 0.5 hour, 2 hours, 4 hours, 1 day and 7 days after 
injury, anesthetized animals were transcardially perfused with 100 ml 0.01M phosphate 
buffer saline, followed by 400 ml of ice-cold 4% paraformaldehyde fixative solution in 
0.01M PBS. A 9 mm segment of cervical cord including C5 to C7 was collected and post-
fixed in the same fixative overnight, and then transferred to a solution of 30% sucrose in 
1x PBS for 5 days. Spinal cord segments were embedded in O.C.T compound (Fisher, 
Waltham, MA) for cryostat sectioning. The tissues were cut on a cryostat (LeicaCM 1950; 
Buffalo Grove, IL) in a series of coronal 25-µm-thick sections from 5th to 7th cervical 




After the spinal cord sections were washed in 1xPBS three times at room temperature, 
blocked in 10% normal goat serum (NGS) or normal donkey serum (NDS) blocking 
solution (with 0.1% Triton X-100 in 1xPBS) for 1 hour, then incubated with primary 
antibodies in 5% NGS or NDS and Triton X-100 (0.05% in 1xPBS) at 4°C overnight. After 
washing in 1xPBS three times, sections were incubated with host-specific secondary 
antibodies for 1 hour at room temperature, followed by DAPI staining for 5 min. The 
sections were washed in 1xPBS again three times and coverslips were mounted with 
Fluoromount-G (SouthernBiotech, Birmingham, AL). The primary antibodies and their 
final dilutions were used as follows: anti-RECA1 (blood vessels; 1:200, mouse; Bio-Rad, 
Hercules, CA); anti-GFAP (astrocytes; 1:1000, chicken; Abcam, Cambridge, United 
Kingdom); anti-APC (oligodendrocytes; 1:400, mouse; Abcam); anti-Iba1 (microglia; 
1:500, goat; Abcam); anti-ED1 (macrophages; 1:200, mouse; Abcam); anti-laminin 
(basement membrane of blood vessels; 1:200, rabbit; Millipore); anti-NeuN (neurons; 
1:1000, mouse or rabbit; Millipore); anti-SMI31 (axons; 1:1000, mouse; Biolegend, San 
Diego, CA); anti-MBP (myelin; 1:200, rat; Millipore). Secondary antibodies with either 
goat or donkey host were used in a dilution of 1:1000. All information for antibodies is 
provided in Table 3.1. For co-labeling with IgG and laminin, sections were stained with 
primary and secondary antibodies against laminin regularly as mentioned above; during 
the step of secondary antibody incubation, a fluorescence-tagged anti-rat IgG antibody 
(Cy3, 1:1000; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) was added 
for one hour in room temperature. Detailed information for antibodies is included in Table 
3.1. 
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Table 3.1. Primary and secondary antibodies used in this study 
 





    
Anti-RECA-1 Mouse IgG 1:200 Bio-Rad MCA970R 
Anti-GFAP Chicken IgY 1:1000 Abcam ab4674 
Anti-APC (CC-
1) 
Mouse IgG2b 1:400 Abcam ab16794 
Anti-Iba1 Goat IgG 1:400 Abcam ab5076 
Anti-ED1 
(CD68) 
Mouse IgG 1:200 Abcam ab31630 
Anti-laminin Rabbit IgG 1:100 Millipore ab2034 
Anti-NeuN Rabbit IgG 1:1000 Millipore ABN78 
Anti-NeuN Mouse IgG 1:1000 Millipore MAB377 
Anti-SMI-31 Mouse IgG 1:1000 Biolegend 801601 
Anti-MBP Rat IgG 1:200 Millipore MAB386 
Anti-APC (CC-
1) 
Mouse IgG2b 1:400 Abcam ab16794 
Anti-laminin Rabbit IgG 1:100 Millipore ab2034 
     
Secondary 
Antibodies 
    




1:1000 Abcam A11039 
Alexa Fluor 488 
(green) 
Goat anti Mouse 
IgG 
1:1000 Life Technologies A-11029 
Alexa Fluor 594 
(red) 
Goat anti Rabbit 
IgG 
1:1000 Abcam A11012 
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CY3 Goat anti Rabbit 
IgG 
1:1000 Millipore AP132C 





CY5 Goat anti Mouse 
IgG 
1:1000 Life Technologies A10524 














1:1000 Life Technologies A11055 







 1:1000 Cell Signaling 4082S 





For immunofluorescence labeling, an inverted fluorescent microscopy system (Zeiss 
Axiovert 200 M, Jena, Germany) was used to capture images. The microscope was 
combined with an apotome and interfaced with a digital camera (Zeiss Axio Cam MRc5) 
controlled by a computer. Images were captured using the apotome with software 
(AxioVision v4.8) and output as a cut view image. The images were later assembled and 
quantified in Photoshop CC (Adobe System, San Jose, CA). 
 
Cell counting 
The immunofluorescence-labeled images were assessed to quantify various types of cells. 
At each time point, cells were counted in one section from each region: C5 (remote zone), 
C6 (transitional zone), and C7 (epicenter) (25 μm thickness, every 120th section from the 
epicenter, 3000 μm apart, based on the topographical information of the rat spinal cord, 3 
sections for each animal). Every single positive cell (even partial positive cell at the borders 
of sections) was counted in multi-planes throughout the entire designated area in the 25 μm 
section. 
 
Quantification of blood vessels 
To quantify leaky vessels, the sections were processed with antibodies against IgG and 
laminin; both dorsal white matter and ventral gray matter were examined; the percentage 




Quantification of neuronal density 
To quantify the number of surviving neurons, the sections were processed with antibody 
against NeuN and ventral gray matter was examined; only cells with a clearly visible 
DAPI-labeled nucleus were included; neuronal density was calculated by dividing the total 
NeuN-positive number by the area of contoured ventral gray matter, expressed as average 
cell number per mm2.  
 
Quantification of microglial responses 
To quantify microglia, the total number and the percentage of ramified and 
hypertrophied/amoeboid phenotypic cells were examined in ventral gray matter using 
antibody against Iba1; similar as above, cell density was expressed as average Iba1+ 
number per mm2 and the percentage of ramified and hypertrophied/amoeboid microglia 
were calculated by the number of specific phenotypic cells over total number. 
 
Quantification of astrocytic response 
To quantify density of astrocytes in ventral gray matter, antibody against GFAP was used 
and the cell density was expressed as the average number per mm2. To quantify the average 
astrocyte area in mm2 (Total GFAP area divided by cell number) and the integrated density 
of GFAP, a 300 μm x 300 μm area was selected in the ventral gray matter 500 μm away 





Quantification of axonal count and size, myelin responses 
To quantify axons and myelination, antibodies against SMI-31 and MBP were used and 
the designated dorsal white matter area (a 200 μm x 150 μm area was selected 200 μm 
away from the central canal) was examined. Both axon and myelin were measured using 
ImageJ, expressed as total axon count, average axon size in mm2, total myelin area, and 
myelin area per axon in mm2. 
 
Quantification of oligodendrocytes 
To quantify the density of oligodendrocytes in the dorsal white matter, an antibody against 
APC (CC-1) was used and cell density was calculated the same as counting neuronal 
density. 
 
Statistical analysis  
The data of in vivo diameter were analyzed using a one-way ANOVA of variance test 
followed by a Dunnett’s multiple comparison test. The quantifications of 
immunofluorescence-labeled cell data were presented as average ± standard deviation and 
analyzed using a one-way ANOVA of variance test followed by a Tukey post-hoc test. 
Both analyses used GraphPad Prism 7 (GraphPad Software, Inc.; La Jolla, CA). Statistical 
significance was set at p < 0.05. In vivo permeability data were analyzed using repeated 
measure two-way ANOVA followed by LSD as post-hoc test via SPSS software IBM 




Simultaneous vasodilation and leakage occur in the epicenter and adjacent area  
I first observed the temporal and spatial changes in spinal vasculature induced by SCI in 
vivo (Fig. 3.1A-D). According to my previous studies, this preparation allows assessment 
of the changes in vessel diameter and vascular permeability (Chen et al., 2017). After 
sequentially delivering the tracers to the rat intravenously, I detected the responses of the 
spinal vessels at 0.5 hour, 2 hour, and 4 hour post-injury, compared to baseline and sham 
controls. To observe the regional differences, three segments of the exposed cervical spinal 
cord were observed for vascular changes simultaneously: epicenter (C7), adjacent (C6), 
and remote (C5) cord regions (Fig. 3.1E). 
I confirmed laminectomy alone did not induce any changes in vessel diameter up 
to 4-hour after the procedure (Fig. 3.1A). As early as 0.5 hour after SCI, I found significant 
vasodilation (arrows) and extravasation of blood content (**) in both the injury epicenter 
and the adjacent cord region, whereas no significant change in the remote region (Fig. 
3.1B). Both epicenter and the adjacent region had similar increased fold change in the 
vessel diameter (epicenter: 1.481±0.609, adjacent: 1.472±0.664; p=0.0001, compared to 
baseline; Fig. 3.1F). The vessels in the remote region started to significantly dilate at a 
later time point of 2 hour after SCI and the vasodilation across three regions was persistent 
up to 4 hour post-injury during observation (Fig. 3.1C-D, F). To further identify the 
differential responses in vessel types, I categorized all the spinal vessels into arteries and 
veins based on the criteria of their morphology and red blood cell velocity (Chen et al., 
2017). The response of the veins was similar to the diameter changes in all vessels, whereas 




Figure 3.1. Immediate vascular dilation occurs simultaneously in the epicenter and the 
adjacent zone after SCI.  
Before and after SCI, in vivo imaging of the same spinal vessels from 3 different regions, 
epicenter, adjacent zone, and remote zone, using 2-photon laser-scanning microscopy in 
(A) Sham, (B) 0.5 hour, (C) 2 hour, and (D) 4 hour post-injury. (E) Display of the observed 
regions from 5th to 7th cervical segments during in vivo imaging. Quantification of the 
temporospatial changes of diameters in (F) overall vessels, (G) arteries, and (H) veins. 
Error bars represent ± s.e.m. Groups: 0.5 hour (n=8), 2 hour (n=6), 4 hour (n=12), Sham 
(n=3). *P<0.05, **P<0.01, ***P<0.001, **** P<0.0001 ns, not significant. Scale bar = 
200 µm.  
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vascular responses in both epicenter and the adjacent area were mainly venous dilation. 
The observed blood content extravasation in the parenchyma indicated that vascular 
permeability has changed in response to SCI. Thus, I measured the fluorescent intensity of 
the first Rho-Dextran tracer (red) outside versus inside the vessel to calculate vascular 
permeability (Fig. 3.2A-D). The higher the ratio of outside versus inside, the greater the 
vessel permeability. I found vessels in the epicenter started to leak at 0.5 hour after injury 
and the level of leakage increased within time, as shown in the quantification results (Fig. 
3.2B and E, Epicenter). The adjacent area had elevated vascular permeability 
simultaneously with epicenter, but at a less degree of leakage (Fig. 3.2B and E, Adjacent). 
Compared to these two regions, the remote zone has not shown any significant changes up 
to 4-hour post-injury yet (Fig. 3.2B and E, Remote).  
Based on the observation of immediate vascular responses beyond the initial 
mechanical injury area, I now termed the adjacent area “transitional zone”. 
 
Histological evidence validates vessel leakage in both gray and white matter 
To verify whether the in vivo detected vascular disruption occurs in a deeper and longer 
temporospatial profile, I used immunofluorescence staining against immunoglobin G (IgG) 
and laminin (see Table. 3.1) to identify and quantify disrupted blood vessels in both white 
and gray matter of the spinal cord up to 7 day post-injury (Fig. 3.3 A-F and Fig. 3.4 A-F).  
For white matter, I have chosen the dorsal white matter area close to the central 
canal because this area is located in the direct injury site (Fig. 3.3 G). IgG is considered as 
a marker of disruption in the blood-CNS barrier. In an intact blood vessel, plasma protein 
IgG cannot cross the barrier so there is no leakage of IgG in the spinal cord parenchyma;  
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Figure 3.2. Simultaneous increase of the vascular permeability in the epicenter and the 
transitional zone after SCI.  
In 3 different regions, epicenter, transitional zone, and remote zone, the vessel permeability 
measurement of the same spinal vessels before and after SCI in (A) Naïve, (B) 0.5 hour, 
(C) 2 hour, and (D) 4 hour post-injury. The purple bar measures the fluorescent intensity 
of the rhodamine-dextran dye inside the vessel whereas the white bar measures outside the 
vessel. (E) Quantification of the temporospatial changes of vessel permeability in remote, 
transitional, and epicenter. * compared to no injury control, # compared to 0.5 hour post-
injury, $ compared to 2 hour post-injury. * or # or $ P<0.05, ** or ## or $$ P<0.01, *** 
or ### or $$$ P<0.001. Groups: 0.5 hour (n=8), 2 hour (n=6), 4 hour (n=12), Sham (n=3). 
Scale bar = 50 µm.  
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Figure 3.3. Histological evidence of simultaneous leaky vessels in the epicenter and the 
transitional zone in the white matter.  
In the white matter, (A) normal vessels become leaky, labeled by IgG and laminin, in both 
epicenter and the transitional zone starting (B) 0.5 hour post-injury. The vessels were later 
monitored at various time points: (C) 2 hour, (D) 4 hour, (E) 1 day, and (F) 7 day post-
injury. (G) A schematic diagram showing the observed regions in the white matter. (H) An 
example of the normal and damaged vessel double-labeled by IgG and laminin. (I) 
Quantification of the percentage of IgG+ vessels over total laminin+ vessels. Error bars 
represent ± SD. n=7 for sham, 0.5h, 2h, and 4h post-injury group, n=6 for 1 day and 7 day 
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post-injury group. *P<0.05, **P<0.01, ***P<0.001. Scale bar = 20 µm in (A-F); Scale 
bar = 50 µm in (H).  
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In contrast, damaged blood vessels display IgG leaks outside into the parenchyma (Fig. 
3.3H). Similar to the in vivo imaging results, I found a significant IgG-labeled vessel 
disruption simultaneously in both the epicenter and the transitional zone as early as 0.5 
hour post-injury (Fig. 3.3B and I, Epicenter: 78.23±14.54%, Transitional: 51.76±16.06%; 
p=0.0001, compared to sham controls); the remote zone did not show any drastic leakage 
at the same time point (Fig. 3.3B and I, Remote: 24.01±25.13%; p=0.2305, compared to 
sham controls). This phenomenon remained at 2 hour and 4 hour post-injury (Fig. 3.3C-
D). At 1 day post-injury, IgG leakage became significantly increased in the remote zone 
(Fig. 3.3E and I, Remote: 44.63±18.91%; p=0.0034, compared to sham controls). Then 
my observation found the level of leakage across three regions was persistent up to 7 day 
post-injury (Fig. 3.3F and I, Remote: 52.2±7.279%, p=0.0006; Transitional: 
52.86±7.608%, p=0.0002; Epicenter: 56.33±14.74%, p=0.0001).  
For gray matter, I assessed the area of ventral horn due to its high vulnerability in 
response to SCI (Fig. 3.4G). Similar to dorsal white matter, the epicenter region displayed 
significant IgG leakage starting at 0.5 hour post-injury (Fig. 3.4B and H). Both the lesion 
epicenter and the transitional zone responded within 2 hour after injury, whereas the remote 
zone has no significant increase in vessel leakage (Fig. 3.4A-F and H). These results 
collectively validate that vessel leakage occur in both white and gray matter but in a 
differential spreading pattern along the dorsal-ventral axis and rostral-caudal axis.  
 
Vascular disruption occurs prior to neuronal loss in the transitional zone 
To examine the injury-induced neuronal loss, I immunofluorescent-labeled NeuN and 
DAPI to assess the neuronal density in the same area of ventral horn across three regions  
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Figure 3.4. Histology also validates the vessel leakage in the gray matter.  
In the gray matter, (A) normal vessels also become leaky in the epicenter starting (B) 0.5 
hour post-injury and the transitional zone starting (C) 2 hour post-injury. The vessels were 
later monitored at other various time points: (D) 4 hour, (E) 1 day, and (F) 7 day post-
injury. (G) A schematic diagram showing the observed regions in the gray matter. (H) 
Quantification of the percentage of IgG+ vessels over total laminin+ vessels. Error bars 
represent ± SD. n=7 for sham, 0.5h, 2h, and 4h post-injury group, n=6 for 1 day and 7 day 
post-injury group. *P<0.05, **P<0.01, ***P<0.001. Scale bar = 100 µm in (A-F).  
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(Fig. 3.5G). In the sham controls, the neuronal density is approximately 200 per mm2 
across three regions (Fig. 3.5A and H, Remote: 221.9±33.89; Transitional: 189.4±32.63; 
Epicenter: 212.1±51.28, p>0.05). At 0.5 hour and 2 hour post-injury, the neuronal density 
remained statistically unchanged (Fig. 3.5B-C). The epicenter showed a significant decline 
in the neuronal density of the ventral horn at 4 hour after SCI (Fig. 3.5D, 143.50±39.61 per 
mm2) and continued to decrease up to 7 day post-injury (Fig. 3.5F, 70.58±21.55 per mm2). 
The transitional zone showed a delayed decrease at 1 day post-injury (120.30±33.46 per 
mm2) and persisted up to 7 day after injury (114.10±11.62 per mm2). No statistically 
significant decrease was shown in the remote zone. Note that in the transitional zone the 
neuronal loss (1 day post-injury) lagged the vascular disruption (2 hour post-injury). 
Therefore, this result identified a time window between vascular leakage and neuronal loss 
in the transitional zone.  
 
Microglial activation also occurs after vascular changes in the transitional zone 
To determine whether inflammatory responses associated with the detected vascular and 
neuronal changes, I investigated the microglial response in the ventral horn, double-labeled 
by Iba1 and DAPI (Fig. 3.6A-B). Besides evaluating the changes in cell density, I also 
categorized the microglia into two subtypes based on morphology. Microglia in the CNS 
is known for transforming from a ramified/quiescent state into a hypertrophied or 
amoeboid state in response to a traumatic insult or stress (Fig. 3.6C) (Xu et al., 2016, 
Davalos et al., 2005, Nimmerjahn et al., 2005, Davis et al., 1994). In the sham controls, the 
resident microglia present its ramified morphology across all three regions (Fig. 3.6D). At 
0.5 hour post-injury, microglia has not shown any changes in all three regions, including  
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Figure 3.5. Neuronal loss lags vessel leakages in the transitional zone.  
In 3 different regions (epicenter, transitional zone, and remote zone), the number of 
neurons (double-labeled by NeuN and DAPI) was counted in (A) Sham, (B) 0.5 hour, (C) 
2 hour, (D) 4 hour, (E) 1 day, and (F) 7 day post-injury. In the epicenter, the neuronal loss 
started at 4 hour post-injury; in the transitional zone, the neuronal loss started at 1 day post-
injury and this lags behind vessel leakages. (G) A schematic diagram showing the observed 
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regions in the gray matter. (H) Quantification of neuron density (NeuN+/DAPI+). Error 
bars represent ± SD. n=7 for sham, n=8 for 0.5h, 2h, and 4h post-injury group, n=6 for 1 
day and 7 day post-injury group. *P<0.05, **P<0.01, ***P<0.001. Scale bar = 200 µm.  
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Figure 3.6. Microglial activation also lags vascular changes in the transitional zone.  
(A) A schematic diagram showing the observed regions in the gray matter. (B) 
Representation of the location for quantification of the microglial process area. (C) An 
example of the ramified and hypertrophied/amoeboid microglia double-labeled by Iba1 and 
DAPI. In 3 different regions (epicenter, transitional zone, and remote zone), (J) the total 
number, (K) ramified microglia cell number, (L) percentage of the hypotrophy cell 
number, and (M) the area of microglial process were measured in (D) Sham, (E) 0.5 hour, 
(F) 2 hour, (G) 4 hour, (H) 1 day, and (I) 7 day post-injury. Error bars represent ± SD. n=6 
for sham, 0.5h, 2h, 4h, 1 day and 7 day post-injury group. *P<0.05, **P<0.01, 
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***P<0.001. Scale bar in (B) is 200 µm; Scale bar = 20 µm in (C); Scale bars = 20 µm in 
(D-I).  
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the total microglial density, the percentage of ramified or hypotrophy microglial cells, and 
the area of microglial processes (Fig. 3.6E, J-M). Starting at 2 hour post-injury, the 
epicenter showed a pattern of decreased ramified/ increased hypotrophy microglia with no 
change in total cell density, whereas the other two zones remained no significant changes 
(Fig. 3.6F). This trend was persistent at 4 hour post-injury, except for the decrease in the 
area of processes in both epicenter and transitional zone (Fig. 3.6G and M). At 1 day post-
injury, both the reduced ramified microglia and increased hypotrophy microglia ratio were 
markedly changed across three regions while the total number maintained (Fig. 3.6H). At 
7 day post-injury, the total number of microglia was drastically increased across all three 
regions, indicating possible microglial proliferation or cell migration from other areas; the 
ratio of ramified and hypotrophy microglia returned to level of sham controls in both 
remote and transitional zone, whereas the significant difference remained in the epicenter; 
the area of microglial processes also increased in the epicenter (Fig. 3.6I). Thus, I 
determined that microglial responses also fall behind the vascular disruption in the 
transitional zone. 
 
Reactivation of astrocytes also lags vascular changes 
Astrocytes are reportedly contributing to the barrier properties by extending end feet of 
processes towards the basal lamina layer outside ECs, indicating an important role 
associated with changes in the vascular permeability (Abbott et al., 2010). I first assessed 
the density of GFAP+/DAPI+ cells, followed by the cell size and the level of GFAP 
expression in the ventral gray matter (Fig. 3.7). The spinal cord astrocytes display a typical 
protoplasmic morphology with the stellate shape in sham controls (Fig. 3.7A). At 0.5 hour   
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Figure 3.7. Reactivation of astrocytes lags vascular changes in the gray matter.  
In 3 different regions (epicenter, transitional zone, and remote zone), the number of 
astrocytes (double-labeled by GFAP and DAPI) was counted in (A) Sham, (B) 0.5 hour, 
(C) 2 hour, (D) 4 hour, (E) 1 day, and (F) 7 day post-injury. (G) A schematic diagram 
showing the observed regions in the gray matter. (H) Quantification of astrocyte density 
(GFAP+/DAPI+). (I) Representation of the location for quantification of average astrocyte 
size and integrated density. (J) Quantification of average astrocyte size in mm2. (K) 
Quantification of the astrocyte integrated density in the unit. Error bars represent ± SD. 
n=7 for sham, n=8 for 0.5h, 2h, and 4h post-injury group, n=6 for 1 day and 7 day post-
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injury group. *P<0.05, **P<0.01, ***P<0.001, **** P<0.0001. Scale bars = 20 µm in (A-
F). Scale bar = 200 µm in (I).  
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after SCI, no changes occurred in all astrocytic responses (Fig. 3.7B, H, J and K). Starting 
at 2 hour post-injury, the astrocytes in the epicenter showed increased GFAP expression 
(Fig. 3.7C). The continuous GFAP elevation in the epicenter led to a marked reduction in 
cell density of astrocytes at 4 hour post-injury; meanwhile, the GFAP expression elevated 
significantly in the transitional zone but no changes in cell density (Fig. 3.7D). At 1 day 
post-injury, the epicenter restored to a similar level of cell density as sham controls; 
however, the average size of cell body slightly increased and the GFAP expression remains 
high; Besides the transitional zone possessed a high level of GFAP expression, no other 
significant changes were found in both remote and transitional zone (Fig. 3.7E). At 7 days 
post-injury, the epicenter showed a marked increase of cell density, as well as average cell 
size and GFAP expression; the transitional zone continued to show elevated GFAP 
expression but no changes in density and cell size (Fig. 3.7F). My data demonstrated that 
GFAP signal started to elevate in the transitional zone at 4 hour post-injury, slightly lagging 
the vascular leakage demonstrated earlier.  
 
The changes in another neuronal component: axonal loss and myelin response 
To determine the temporal relationship between vascular disruption and other neuronal 
components, I assessed the axons and myelination (co-labeled by SMI-31 and MBP) in the 
dorsal white matter area above the central canal (Fig. 3.8B). It is the same area where I 
quantified vascular leakage (Fig. 3.3). I first counted the axon number and average axon 
size using imageJ. Compared to sham controls, SCI has not led to any significant changes 
at 0.5 hour after injury; starting at 2 hour post-injury, the epicenter showed reduced number 
of axons and the phenomenon remained at 4 hour post-injury; at 1 day post-injury, the  
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Figure 3.8. Axonal loss and myelin responses.  
(A) In 3 different regions (epicenter, transitional zone, and remote zone), the axon labeled 
by SMI-31 was stained in Sham, 0.5 hour, 2 hour, 4 hour, 1 day, and 7 day post-injury. (B) 
A schematic diagram showing the observed regions in the white matter. (C) In 3 different 
regions (epicenter, transitional zone, and remote zone), the axon and myelin double-labeled 
by SMI-31 and MBP were stained in Sham, 0.5 hour, 2 hour, 4 hour, 1 day, and 7 day post-
injury. (D) Quantification of axon number density in mm2. (E) Quantification of average 
axon size in mm2. (F) Quantification of total myelin area in mm2. (G) Quantification of 
myelin area per axon in mm2. Error bars represent ± SD. n=7 for sham, n=8 for 0.5h, 2h, 
and 4h post-injury group, n=6 for 1 day and 7 day post-injury group. * compared to sham 
control, # compared to 7 day post-injury. * or # P<0.05, ** or ## P<0.01, *** or ### 
P<0.001, **** or #### P<0.0001. Scale bars = 5 µm in (A) and (C).  
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axonal number was reduced across all three regions while no changes were observed for 
average size of axons; at 7 day post-injury, the axonal number was further reduced and the 
axonal size increased in the epicenter (Fig. 3.8A, D-E). 
To assess the myelin response to the injury, I also calculated total MBP+ area and 
MBP+ area per axon (Fig. 3.8C, F-G). Interestingly, myelin immediately responded to the 
injury at 0.5 hour post-injury in all three regions; the elevation in both total area and myelin 
area per axon were persistent up to 4 hour post-injury. The elevation indicated the myelin 
became less compact and no longer wrapping around the axons; At 1 day and 7 day post-
injury, the myelin structures had a sharp decrease in all three regions. In the transitional 
zone, the myelin responded to the injury simultaneously with the vascular damage in the 
same area. These changes in myelin structures may be further confirmed by electron 
microscopy (EM). 
 
The loss of oligodendrocytes  
To assess the changes in oligodendrocytes in the same dorsal white matter area, I counted 
the cell density of CC1+ (APC) oligodendrocytes across the three regions (Fig. 3.9). In the 
epicenter, the oligodendrocytes immediately died at 0.5 hour post-injury and remained the 
same up to 7 day post-injury; in both the remote and transitional zone, the number of 
oligodendrocytes remained stable for the first 4 hours after injury, and then exhibited a 
drastic drop at 1 day which was maintained up to 7 day post-injury (Fig. 3.9B-F, H). The 





Figure 3.9. The loss of oligodendrocytes parallels the timescale for myelin response.  
(A) In 3 different regions (epicenter, transitional zone, and remote zone), quantification of 
oligodendrocyte density (double-labeled by CC-1 and DAPI) was counted in (A) Sham, 
(B) 0.5 hour, (C) 2 hour, (D) 4 hour, (E) 1 day, and (F) 7 day post-injury. (G) A schematic 
diagram showing the observed regions in the white matter. (H) Quantification of 
oligodendrocyte density per mm2. Error bars represent ± SD. n=7 for sham, n=8 for 0.5h, 
2h, and 4h post-injury group, n=6 for 1 day and 7 day post-injury group. * compared to 
sham control, # compared to 7 day post-injury. * or # P<0.05, ** or ## P<0.01, *** or ### 
P<0.001, **** or #### P<0.0001. Scale bars = 20 µm in (A-F).   
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Discussion 
The goal of this study was to characterize a temporospatial map of the acute vascular 
responses correlated with neuronal changes and other cellular changes in three consecutive 
cord segments, rostral to the epicenter, following a contusive spinal cord injury. To date, 
few studies have examined the temporospatial profiles of contusive SCI at such acute time 
points, and to my knowledge, this is the first study to investigate the temporal relationship 
between vascular responses and neuronal damage.  
Using a novel in vivo imaging method, I revealed the immediate appearance of 
injury-induced vasodilation and increased vascular permeability beyond the injury 
epicenter in living animals. Several vascular responses post-SCI were reported, including 
hemorrhage and loss of microvessels. An ultrastructural study reported arteriolar 
vasospasm at 24 hours after SCI (Anthes et al., 1996). However, my study provides the 
first direct evidence of SCI-induced vasodilation to date. Little information is available to 
understand its underlying mechanisms. According to the studies in autonomic dysreflexia, 
the one proposed mechanism is that SCI leads to the sudden loss of sympathetic regulation 
on the smooth muscle cells surrounding the blood vessel walls leading to the dilation of 
the vessels (Hagen et al., 2012). Vasodilation has been linked to nitric oxide (NO), which 
has a vascular relaxation effect on the smooth muscle cells (Waldman and Murad, 1988, 
Moncada and Higgs, 1993). Further investigations are required before vasodilation can be 
targeted for therapeutic interventions in an SCI model. One key question needs to be 
addressed first is whether post-injury vasodilation is detrimental or beneficial for the 
recovery of SCI. My finding of increased vascular permeability is consistent with the HRP 
tracing studies of Noble and Wrathall (Noble and Wrathall, 1988, Noble and Wrathall, 
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1989b). In addition, the range of immediate vascular leakage went beyond the injury site. 
Increased vascular permeability indicates the altered structure of the blood-spinal cord 
barrier (BSCB), leading to intraparenchymal hemorrhage and extravasation of the plasma 
protein. These early events of vascular disruption often coincide with tissue damage or 
cavity at a later time point. Targeting vascular disruption can serve for two purposes: a 
proof of concept that vascular damage contributes to tissue damage and the pursuit for 
neuroprotective treatments. The mechanisms underlying increased vascular permeability 
remain debatable. There are two pathways for substances to travel across the endothelial 
cell layer: paracellular and transcellular transport. The increased vascular permeability may 
be due to changes in either or both pathways. Targeting both pathways to repair the 
damaged vascular membrane and reestablish the normal BSCB can be a potential strategy.  
Based on the temporal difference between the onset of the IgG leakage (30 min) 
and neuronal loss (1 day), I proposed a time window in the transitional zone that could be 
therapeutically relevant. At 2 hour post injury, I found these IgG+ cells near the leaky 
vessels, which the morphology resembles neurons. Previous studies have indicated that the 
uptake of leaked IgG by neurons contributes to neuronal dysfunction following disruption 
of BBB (Michalak et al., 2012, Goasdoue et al., 2019, Johnson et al., 2018, Giris et al., 
2017). Thus, this may further support the role of vascular damages in neuronal damage 
following SCI. A slight but not significant decrease of neuronal density in the remote zone 
at 1 day post-injury reflects there might be additional mechanisms responsible for the 
neuronal damages. 
I detected microglial activation as early as 2 hour post-injury in the epicenter, 
shown as a morphological change from ramified to hypertrophied, up to 7 day post-injury. 
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The morphological changes of microglia, including retraction of processes and increased 
amoeboid morphology, often indicate inflammatory responses and/or phagocytotic 
features. The emergence of microglial response in the epicenter suggests a potential role of 
compromised BBB contributing to the activation of resident microglia, as demonstrated by 
in vivo two-photon microscopic studies (Nimmerjahn et al., 2005, Huber et al., 2016, Ju et 
al., 2018, Kozai et al., 2012). At 7 day post-injury, I also detected increased cell density. It 
can be attributed to the recruitment of monocyte-derived macrophages and/or proliferation. 
In both remote and transitional zones, I found a delayed activation starting at 1 day post-
injury and increased cell density at 7 day post-injury. This different pattern of changes may 
be due to the injury severities received in these zones. Again, my results showed the 
microglial activation lags vascular leakage in the transitional zone, suggesting the role of 
vascular disruption in microglial activation of the non-direct injury area. Additionally, a 
previous study also suggested a potential molecular mechanism linking vascular disruption 
to microglial activation: BBB disruption exposed the parenchyma tissue to many blood-
derived plasma proteins; One protein called fibrinogen binds to CD11b receptor of 
microglia, triggers increased expression of TNF-alpha, which switch resident microglia 
into a pro-inflammatory phenotype. The microglia-released TNF-alpha further showed 
neurotoxicity via ER stress signaling (Piers et al., 2018). 
Similar to microglial activation, I also found reactive astrocytes starting at 2 hour 
post-injury in the epicenter, shown as elevated intensity of GFAP expression, up to 7 day 
post-injury. Again, this phenomenon occurred after vascular disruption. As one component 
of the neurovascular unit, it makes sense that astrocytes become quickly activated after the 
disruption of blood-CNS barrier. I also observed the enlarged size of astrocytes at 1 day 
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post-injury and this continues to increase up to 7 day post-injury, suggesting further 
morphological changes which may contribute to the formation of the glial scar. The cell 
density of astrocytes first decreased at 4 hour post-injury, indicating cell loss in response 
to the injury. Then the cell density increased at 7 day post-injury, which is likely due to 
proliferation and/or cell migration from the uninjured area. In the transitional zone, the 
increased GFAP expression was at 4 hour post-injury and lasted up to 7 day post-injury. 
No sign of enlarged size or cell density was seen in this region. Although a much attenuated 
response, the activation of astrocytes still lags vascular disruption in the transitional zone. 
Unlike microglial response, no detection of reactive astrocytes was seen in the remote zone. 
The microglia likely have more motile responses compared to astrocytes.  
For quantification of axons and myelin, I chose to evaluate the dorsal white matter 
area because it is where the axonal tracts reside (both ascending and descending) and 
receive a direct impact from the contusive injury. In the epicenter, the number of axons 
starting to decrease at 2 hour post-injury and the trend continued up to 7 day post-injury. 
The axonal loss here is most likely due to the direct mechanical injury. Meanwhile, the 
area of myelin and myelin area per axon showed an increase at 2 hour and 4 hour post-
injury, followed by reducing back to sham level. An explanation of this data is that the 
myelin becomes swollen and disorganized loose structure as shown in enlarged area, and 
it may be fragmented and phagocytized by infiltrated macrophages resulted in the reduced 
area at 7 day post-injury. The axons also showed signs of swelling due to the significant 
increase in size at 7 day post-injury, which is consistent with previous reports on swollen 
axonal endings following SCI (Hill, 2017). In both transitional and remote zones, the 
number of axons started to decrease at 1 day post-injury and continued at 7 day post-injury. 
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The observed axons include both ascending and descending tracts. Previous studies in 
thoracic SCI transection models using tracer labeling show specific prolonged dieback of 
CST descending axons ranging from 2-3 mm (Hill et al., 2001, Seif et al., 2007). My results 
show a longer distance of axonal dieback ranging from 6-7.5 mm. This may be due to 
differences in three factors, including injury models, regional-specific axon vulnerability, 
and the combinational observation of both ascending and descending tracts in the lesioned 
region. 
Previous studies found oligodendrocytes are extremely vulnerable to the toxic 
environment of acute SCI. Multiple factors could lead to oligodendrocyte loss, including 
excitotoxicity, oxidative stress, blood component, infiltrating neutrophils and activated 
microglia release product, etc (Almad et al., 2011). I observed an acute loss of 
oligodendrocytes as early as 0.5 hour post-injury in the epicenter, and this supports the 
conclusion from previous findings. And this loss persisted up to 7 day post-injury, showing 
no sign of replenishment of the oligodendrocytes either from proliferation or recruitment 
from elsewhere during the first week after injury. The early vascular disruption in the 
transitional zone may exert oxidative stress, which could contribute to the delayed loss of 
oligodendrocytes occurring at 7 day after injury. The microglial activation that occurred at 
1 day post-injury may trigger the oligodendrocyte loss in the remote zone at 7 day post-
injury, which may be mediated by nitric oxide (Merrill et al., 1993, Shuman et al., 1997, 
McTigue and Tripathi, 2008). 
Taken together, my results indicate that vascular disruption occurs prior to neuronal 
loss in the transitional zone, suggesting a time window between these two phenomena. The 
findings bring up the possibility that vascular events could be a potential target to reduce 
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the regional neuronal loss. To further address this hypothesis, additional studies need to be 
done to target acute vascular events, including intraparenchymal hemorrhage, blood-spinal 
cord barrier disruption, and blood protein extravasation. Not only could targeting these 
acute vascular events test the alternative underlying mechanism for secondary injury 
progression, but also it could provide potential targets for neuroprotection after SCI.  
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CHAPTER 4 
TARGETING VASCULAR LEAKAGE WITH INTRAVENOUS DELIVERY OF 
FERULIC ACID (FA) - GLYCOL CHITOSAN (GC) NANOPARTICLES 
FOLLOWING SPINAL CORD INJURY 
 
Hypothesis 
The intravenous delivery of FA-GC, a nanoparticle encapsulated membrane sealant, can 
prevent or reduce progressive disrupted vascular changes, resulting in acute 
neuroprotection and long-term functional recovery after an acute SCI. 
 
Introduction 
My previous work demonstrated a time window between vascular dysfunction and 
neuronal damage in the transitional zone. To further investigate whether these early 
vascular damages contribute to the following neuronal damage, I need to identify feasible 
vascular targets. Previously detected acute vascular dysfunctions include vasodilation and 
increased vascular permeability. The physiological role of vasodilation following SCI 
remains elusive. Less effort has been spent on its involvement in neuronal damage. On the 
other hand, increased vascular permeability indicates the disruption of the blood-spinal 
cord barrier and the extravasation of all types of plasma proteins into the parenchymal 
tissue. Leaked plasma proteins include albumin, fibrinogen, fibronectin and 
immunoglobulin G, etc. Among them, a few studies reported the neurotoxicity of 
fibrinogen (Piers et al., 2018, Schachtrup et al., 2007, Ill-Raga et al., 2015). Thus, targeting 
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vascular leakage is more likely to provide a neuroprotective effect following SCI. An 
attractive strategy to target vascular leakage is to reestablish the normal BSCB. 
Previously, a colleague of mine reported a neuroprotective nanoparticle composed 
of ferulic acid (FA)-modified glycol chitosan (GC), represented by the acronym FA-GC, 
that accumulated at the lesion site and restored locomotor function following SCI (Wu et 
al., 2014) (Fig. 4.1). FA is a compound in the family of phenolic acids and is abundant in 
plant cell wall components (Mancuso and Santangelo, 2014). Chitosan, produced mainly 
from the exoskeleton of crustaceans, has been shown to achieve vascular hemostasis 
(Koksal et al., 2011, Gustafson et al., 2007, Brandenberg et al., 1984), decrease blood loss 
(Kunio et al., 2013), enhance angiogenesis (Zhou et al., 2013), promote endothelial repair 
(Zhao et al., 2013, Okamoto et al., 2002, Hoekstra et al., 1998, Esposito et al., 2013) in 
various animal models. Because chitosan is dissolved poorly in an aqueous solution with 
neutral pH, I employed a water-soluble GC derived from the primary amines in original 
chitosan (Na et al., 2012, Wu et al., 2014). Wu and his team found that FA-GC 
nanoparticles displayed a half-time of 20 hours retained in blood circulation and were only 
detected in the lesion site of the injured spinal cord (Fig. 4.1C-D). The packed red blood 
cells and blood clots were observed in the gray matter, demonstrating disruption of the 
blood vessels induced by the physical impact (Fig. 4.1E). To date, few studies reported 
chitosan-based therapy in the CNS (Brandenberg et al., 1984) and few, if any, delivered as 
a nanoparticle through iv. In my study, I decided to use the membrane sealant feature of 
FA-GC nanoparticles to seal the damaged vascular membrane. FA can also act as a strong 




Figure 4.1. FA-GC nanoparticles exhibited long blood retention time and targeted delivery 
to injured spinal cord.  
(A) Properties of FA-GC nanoparticles. (B) Size distribution and TEM image (scale bar: 
300 nm). (C) Blood retention kinetics of FA-GC(-Cy5.5) and GC(-Cy5.5) in SCI rats. The 
fluorescence of FA-GC(-Cy5.5) in blood samples, drawn at different time points, were 
visualized (top). (D) Fluorescence imaging and quantification of FA-GC(-Cy5.5) in normal 
and injured spinal cords. (E) Distribution of FA-GC(-Cy5.5) in the injured spinal cord. A 
cross section through the injury epicenter shows the distribution of FA-GC (E1). Dotted 
squares represent high magnified images of the distribution of FA-GC (red) in the gray 
matter (E2). White arrowheads in E2 indicate packed red blood cells (Scale bar = 100 µm 
for E1 and 5 µm for E2). Adapted from (Wu et al., 2014).  
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My studies showed that an innovative nanoparticle, FA-GC, reduced the injury-
induced vascular leakage, promoted region-specific neuroprotection and partial forelimb 
functional recovery when given within the 15 minutes following cervical contusion SCI in 
rats. Meanwhile, the effect of FA-GC provided a proof of concept that early vascular 
damages occurred in the transitional zone may contribute to later neuronal loss. The results 
of this study elucidate the potential benefits and shortcomings of targeting early vascular 
leakage using a nanoparticle with a membrane sealant effect in a clinically-relevant 
cervical contusive SCI model in rats. 
 
Materials and methods 
Animals 
Six weeks old female Sprague-Dawley rats (180-220 g, Envigo RMS, Inc., Indianapolis, 
IN) were housed with an air filter in an environmentally-controlled facility with a 12-
hour/12-hour light/dark cycle, and accessible to food and water freely throughout the entire 
study. In this study, a total of 42 rats were used and randomly assigned into 3 groups of 
experiments: in vivo spinal vascular imaging (n = 8), immunofluorescence labeling (n = 
16), and forelimb functional assessments (n = 18). All procedures were approved by the 
Institutional Animal Care and Use Committee of Indiana University School of Medicine 
and Institutional Biosafety Committee and were strictly following the National Institutes 





Spinal cord injury model 
In preparation for surgery, the rats were injected with ketamine (87.7mg/kg) and xylazine 
(12.3mg/kg) mixture intraperitoneally to enter deep anesthesia. For all SCI performed in 
this study, the animals received a mild-to-moderate contusive injury at the midline of 7th 
cervical spinal cord segment (tissue displacement = 0.800mm) after laminectomy. The SCI 
was performed using a Louisville Injury System Apparatus (LISA) device according to a 
previously established protocol from Xu lab (Zhang et al., 2008). 
 
In vivo spinal vascular imaging 
This procedure was performed following the exact steps in the previous chapters. Also, the 
procedure was performed as previously described (Chen et al., 2017). In brief, two different 
fluorescein-conjugated dextran tracers (Rhodamine B isothiocyanate-dextran (Rho-
dextran); Fluorescein isothiocyanate-dextran (FITC-dextran), 70kDa, Sigma-Aldrich, 4 
mg/mL in saline) were intravenously given to anesthetized rats via EJV before and at 2 
hours after SCI. Under 2P-LSM, Z-stack images across C5-C7 region (epicenter, 
transitional zone, remote zone) were taken to track dynamic changes in spinal blood 
vessels, including vessel diameter and vascular permeability. There were two groups in 
this experiment: FA-GC treatment (n =4; 5 mg/ml, 1ml) and saline control group (n =4). 






Measurement of vessel diameter and vascular permeability 
The acquired Z-stack images were analyzed via imageJ to measure changes in vessel 
diameter and vascular permeability. The images were first calibrated true to scale. For 
vessel diameter, a line is drawn perpendicular to the long axis of the vessel segment to 
measure the diameter. The diameter of the blood vessel is determined by the average of 
three measurements across the vessel segment. For vascular permeability, a probe of a 200 
μm line is drawn both inside and outside the vessel to measure the fluorescence integrated 
density. The vascular permeability is calculated as the ratio of the outside value divided by 
the inside value.  
 
Preparation and delivery of FA-GC nanoparticles in vivo 
According to the work of Wu and colleagues, ferulic acid–glycol chitosan nanoparticles 
(FA-GC) were dissolved in 0.9% sodium chloride solution by sufficient sonication to 
produce a homogeneous solution of FA-GC nanoparticles (Wu et al., 2014). Each aliquot 
was 1 ml and prepared at the day of surgery. FA-GC (22.7mg/kg, 1ml in saline) were 
intravenously administrated to the SCI rats via the same EJV catheter previously used for 
tracer injection within 15 minutes post contusive injury. 
 
Tissue processing for histological assessments 
For the groups of animals for histological analysis, tissues were collected and processed 
adapting from a previous publication (Liu et al., 2006). At 0.5 hour, 2 hours, 4 hours, 1 day 
and 7 days after injury, anesthetized animals were transcardially perfused with 100 ml 
0.01M phosphate buffer saline, followed by 400 ml of ice-cold 4% paraformaldehyde 
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fixative solution in 0.01M PBS. A 9 mm segment of cervical cord including C5 to C7 was 
collected and post-fixed in the same fixative overnight, and then transferred to a solution 
of 30% sucrose in 1x PBS for 5 days. Spinal cord segments were embedded in O.C.T 
compound (Fisher, Waltham, MA) for cryostat sectioning. The tissues were cut on a 
cryostat (LeicaCM 1950; Buffalo Grove, IL) in a series of coronal 25-µm-thick sections 
from 5th to 7th cervical segments mounted on slides, and stored at -20°C. The sections were 
then processed for immunofluorescence labeling. 
 
Immunofluorescence labeling 
After the spinal cord sections were washed in 1xPBS three times at room temperature, 
blocked in 10% normal goat serum (NGS) or normal donkey serum (NDS) blocking 
solution (with 0.1% Triton X-100 in 1xPBS) for 1 hour, then incubated with primary 
antibodies in 5% NGS or NDS and Triton X-100 (0.05% in 1xPBS) at 4°C overnight. After 
washing in 1xPBS three times, sections were incubated with host-specific secondary 
antibodies for 1 hour at room temperature, followed by DAPI staining for 5 min. The 
sections were washed in 1xPBS again three times and coverslips were mounted with 
Fluoromount-G (SouthernBiotech, Birmingham, AL). The primary antibodies and their 
final dilutions were used as follows: anti-RECA1 (blood vessels; 1:200, mouse; Bio-Rad, 
Hercules, CA); anti-GFAP (astrocytes; 1:1000, chicken; Abcam, Cambridge, United 
Kingdom); anti-APC (oligodendrocytes; 1:400, mouse; Abcam); anti-Iba1 (microglia; 
1:500, goat; Abcam); anti-ED1 (macrophages; 1:200, mouse; Abcam); anti-laminin 
(basement membrane of blood vessels; 1:200, rabbit; Millipore); anti-NeuN (neurons; 
1:1000, mouse or rabbit; Millipore); anti-SMI31 (axons; 1:1000, mouse; Biolegend, San 
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Diego, CA); anti-MBP (myelin; 1:200, rat; Millipore). Secondary antibodies with either 
goat or donkey host were used in a dilution of 1:1000.  
 
Fluorescence microscopy 
For immunofluorescence labeling, an inverted fluorescent microscopy system (Zeiss 
Axiovert 200 M, Jena, Germany) was used to capture images. The microscope was 
combined with an apotome and interfaced with a digital camera (Zeiss Axio Cam MRc5) 
controlled by a computer. Images were captured using the apotome with software 
(AxioVision v4.8) and output as a cut view image. The images were later assembled and 
quantified in Photoshop CC (Adobe System, San Jose, CA).  
 
Quantification of neuron 
To quantify the number of surviving neurons, the spinal cord sections at 7 days post-injury 
(n = 8 for both groups; FA-GC treatment and saline control groups) were double labeled 
with primary antibody against NeuN and DAPI, followed by secondary antibodies. One 
side of the gray matter in the spinal cord was examined; cell density was calculated by 
dividing the total NeuN-positive number by the area of gray matter, and the average cell 
number per mm2 was reported as total neuronal density. The gray matter area was further 
divided into three sub-regions based on the ten-layer Rexed laminae system: dorsal horn 
(lam I-VI), intermediate zone (lam VII), and ventral horn (lam VIII-IX) (Watson, 




Forelimb behavioral assessments  
Prior to all the following behavioral tests, the animals were habituated in the testing room 
for 30 minutes under consistent dimmed lighting conditions. During the first week 
following SCI, each test was evaluated every other day. From the second week to the sixth 
weeks following SCI, each test was assessed once a week. 
 
Part I: adhesive removal 
The somatosensory function of forelimbs was assessed according to a modified adhesive 
removal test for rats (Komotar et al., 2007). After the animal was placed in the testing cage, 
a piece of green paper tape (3.0 cm in length and 1.0 cm in width, standard laboratory tape) 
was wrapped around the forepaw with a consistent placement. The ends of the tape meet 
at the palm side, and the finger tips are slightly exposed from the tape-formed sleeves. 
Once the tape was attached successfully, the animal was placed back to the testing cage 
and two timers were started. The first timer recorded the time when the animals start 
attempts to remove the tape sleeves with either mouth or the other forelimb (contact time). 
The second timer recorded the time it takes for the rat to remove the entire tape (removal 
time). Both contact time and removal time were recorded as a single trial. The maximum 
duration for each trial lasts for 2 minutes. The left and right forelimb were alternatively 
tested, and five trials were performed for each limb. For each time point, both contact time 





Part II: grid walking 
Forelimb skilled motor coordination was evaluated using a grid walking test. The animals 
were tested on an elevated grid (124 x 120 cm2, each grid size is 3.5 x 5.0 cm2; height: 93 
cm). Prior to every session, 70% ethanol and 10% bleach were used to clean the apparatus. 
Two cameras were set up to record travelled distance (activity camera) and footsteps (step 
camera), respectively. The activity camera was located directly above the grid to cover the 
entire grid frame. The step camera was posed at an angle of 20 – 40 degrees diagonally 
upwards. The tests were run by two examiners. To begin the test, one examiner placed the 
animal in the center of the grid, while the other examiner started both cameras and timer 
simultaneously. During a total testing period of 5 min, one examiner counted the total steps 
of each forelimb explored on the grid while the other examiner counted the number of foot 
drops for each forelimb. The percentage of foot fall (% Foot Fall) was calculated as the 
number of error steps divided by the number of total steps. Average of the two forelimbs 
were used as the final value. For travelled distance, the video recorded by the activity 
camera was analyzed using a behavioral tracking software named ANY-MAZE (Stoelting 
Co., Wood Dale, IL). 
 
Part III: modified grip strength 
A modified forelimb grip strength test was applied on a grip strength meter (TSE Systems, 
Inc., Chesterfield, MO) to assess skeletal muscle function according to a previous 
publication (Takeshita et al., 2017). A square metal frame with horizontal metal bars was 
connected to a high-precision force sensor. The metal frame was stably fixed on the metal 
stand vertically and the parallel metal bars were horizontally placed above the ground with 
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a fixed height. Before each trial, the gauge was reset to 0. After placing the animal to grasp 
the same horizontal bar, the rat’s tail was pulled by an examiner in a downward direction. 
As the rat pulls and releases the bar, the maximum force exerted was shown on the digital 
display of the force sensor as unit of pond (1 pond (P) = 0.0098 newton (N)). The criteria 
to validate a trial is that trials were excluded if only one forepaw, or the hindlimbs were 
involved; or the rat turned or left the bar without resistance during the test. At one-minute 
intervals, 10 consecutive measurements were performed on individuals and the average 
was reported as the grip strength. Given that the measurement can be influenced by the 
speed of the tail pull, the procedure was performed at a constant speed sufficiently slow to 
allow the rat to build up a resistance against it. The rat’s body weight was measured after 
the test. To check if changes in body weight have a major effect on grip strength results, a 
Pearson correlation coefficient was analyzed between the body weight and the grip 
strength. 
 
Part IV: rotarod 
Motor performance of forelimbs was tested on rotarod with an accelerating mode (IITC 
Life Science Inc., Woodland Hills, CA; 4-40 rpm, 120 seconds cutoff time, top speed 
peaked at 90 seconds). The rotarod test was adapted to test on rats. The rats were placed 
on the rotarod to freely explore and both the latency and speed at fall were recorded. The 
animals were given five trials with an interval of 10 minutes between trials. Both latency 





The data of in vivo diameter were analyzed using a one-way ANOVA of variance test 
followed by a Dunnett’s multiple comparison test. The quantification of the neuron was 
presented as average ± standard deviation and analyzed using a one-way ANOVA of 
variance test followed by a Tukey post-hoc test. Behavior data were presented as average 
± standard deviation and analyzed using unpaired t test at different time points. All analyses 
above are using GraphPad Prism 7 (GraphPad Software, Inc.; La Jolla, CA). In vivo 
permeability data were analyzed using repeated measure two-way ANOVA followed by 
LSD as post-hoc test via SPSS software IBM Corporation, Armonk, NY. All significance 
was set at p < 0.05. 
 
Results 
FA-GC reduced vascular leakage but did not affect changes in vessel diameter  
I first injected FA-GC (22.7mg/kg, 1ml in saline) i.v. within 15 minutes after SCI, saline 
treatment as vehicle control. Two hours post-injury, in vivo spinal vascular imaging 
revealed changes in vessel diameter and vascular permeability compared to baseline (Fig. 
4.2A). Similar to chapter 3, I observed the vascular changes across all three regions (Fig. 
4.2B, epicenter, transitional zone, and remote zone). FA-GC treated animals had no 
significant changes of vessel diameter in any region compared to the saline-vehicle controls 
(Fig. 4.2C-D). On the other hand, the vascular leakage was significantly reduced in FA-
GC treated animals across all three regions compared to saline controls (Fig. 4.2C, E). 
Here, I demonstrated the positive effect of FA-GC treatment on injury-induced vascular 
leakage in vivo.  
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Figure 4.2. FA-GC reduces vascular leakage but has no effect on the vessel diameter 
following C7 contusion SCI.  
(A) Experimental design and timeline. (B) Schematic drawing. (C) In vivo images at the 
transitional zone at baseline and 2 hour post-injury. The measurements of (D) vessel 
diameter and (E) vascular permeability. n=4 for both SCI + saline and SCI + FA-GC 
groups. * P<0.05, ** P<0.01, *** P<0.001.    
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FA-GC prevented neuronal loss of the ventral horn in the transitional zone  
To assess whether FA-GC treatment prevented neuronal loss in the transitional zone 
following injury, immunofluorescence labeling of NeuN and DAPI was utilized. Since the 
previous chapter reported the neuronal loss in the transitional zone was seen at 1 day and 
7 day post-injury, I observed the neuronal density in FA-GC treated or saline-treated 
animals at 7 day post-injury in all three regions (Fig. 4.3A). I first assessed the total 
neuronal density on one side of the gray matter. Considering the nonuniform distribution 
of the neurons in the gray matter, I also presented the neuronal density when divided into 
three subzones based on the laminae of Rexed: dorsal horn (lam I-VI), intermediate zone 
(lam VII), and ventral horn (lam VIII-IX) (Watson and Kayalioglu, 2009) (Fig. 4.3B). In 
all three regions, no difference was found in total neuronal density compared to saline 
controls (Fig. 4.3C). However, FA-GC treated animals had a significant increase of 
neuronal density in the ventral horn of transitional zone compared to its saline controls, 
while no significant differences were seen within the subzone of ventral horn in either 
epicenter or remote zone (Fig. 4.3D). In all three regions, no difference in neuronal density 
was observed in either the dorsal horn or intermediate zone (Fig. 4.3E-F). Although no 
rescue of neurons was seen in the lesion center, FA-GC treatment reduced neuronal loss 
from the ventral horn in the transitional zone.  
 
The FA-GC treatment promoted partially improved forelimb motor function 
To determine the functional efficacy of intravenously delivered FA-GC treatment, four 
different forelimb behavior assessments were evaluated: adhesive removal, grid walking, 
grip strength, and rotarod. The assessments were performed every other day for the first   
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Figure 4.3. FA-GC prevented neuronal loss of the ventral horn in the transitional zone.  
(A) Experimental timeline and schematic drawing. (B) For quantification of neuronal 
density, the gray matter of spinal cord is divided into three sub-regions based on laminae:  
dorsal horn (lam I-VI), intermediate zone (lam VII), and ventral horn (lam VIII-IX). 
Quantification of neuronal density across three regions (remote, transitional, and lesion 
center) in (C) total, (D) ventral horn, (E) dorsal horn, and (F) intermediate zone. Error bars 
represent ± SD. n=8 for both SCI + saline and SCI + FA-GC groups. * P<0.05, ** P<0.01, 
*** P<0.001.    
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week post-injury, and once a week from the second week to the sixth weeks following SCI. 
As a new injury model, the C7 midline contusion SCI model was first evaluated using the 
abovementioned forelimb tests to demonstrate the sensitivity of the behavior tests, 
compared to sham controls. Then two other groups of animals were used to assess the 
functional differences between FA-GC treated animals and saline-vehicle controls (Fig. 
4.4). Overall, FA-GC treatment promoted partial recovery of forelimb motor function, 
specifically shown in the grip strength test. 
 
Part I: adhesive removal 
Two parameters were assessed in this test: the latencies for contact or removal of the green 
tape. For contact latency, a slight but not significant deficit (p=0.062) was observed in SCI 
group at 1 day post-injury when compared to sham controls. Then the SCI animals showed 
a significant increase at 2 weeks post-injury when compared to sham controls (p=0.005). 
No other significant difference was seen in any other timepoint (Fig. 4.5A). For removal 
time, the test did not show any significant differences between SCI and sham controls until 
4 weeks post-injury (p=0.002). No significant difference was seen at 5 weeks and 6 weeks 
post-injury (Fig. 4.5B).  
In FA-GC treated animals, there was a slight but not significant increase of contact 
time at 3 days post-injury when compared to saline-treated animals (p=0.055). FA-GC 
treated animals did not show any significant improvement compared to saline-treated 
controls until 3 weeks post-injury (p=0.031). At 4 weeks post-injury, the trend of 
improvement was seen in the FA-GC treated animals but with no statistical significance.   
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Figure 4.4. Experimental design and timeline for behavior assessments. 
Four behavioral tests were used to assess forelimb functions: adhesive removal, grid 
walking, grip strength and rotarod. Four animal groups were included: Sham, SCI, SCI 
with i.v. injection of saline, and SCI with i.v. injection of FA-GC. Each test was evaluated 
every other day for the first week, and once a week from the second week to the sixth 
weeks following SCI.  
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Figure 4.5. Adhesive removal test. 
(A-B) Between Sham and SCI groups, both contact time and total removal time were 
recorded up to 6 weeks. (C-D) Between SCI + Saline and SCI + FA-GC groups, both 
contact time and total removal time were recorded up to 6 weeks. Error bars represent ± 
SD. n=4 for the sham group, n=3 for SCI and SCI + saline groups, and n=8 for SCI + FA-
GC group.  * P<0.05, ** P<0.01, *** P<0.001.  
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At 5 weeks post-injury, the trend maintained at a slight yet not significant level (p=0.056). 
At 6 weeks post-injury, no difference was seen between FA-GC-treated and saline-treated 
animals (Fig. 4.5C). For removal time, FA-GC treatment showed significant early deficit 
at 3 day post-injury (p=0.021), which matched with the difference in contact time at the 
same timepoint. However, no significant difference was seen at any other timepoint (Fig. 
4.5D). 
 
Part II: grid walking 
Grid walking provided two parameters: percentage of foot fall (% foot fall) and total 
traveled distance (total distance). The % foot fall evaluates the accuracy of foot placement 
on the grid while walking, whereas the total distance represents the activity of the animals. 
For % foot fall, SCI animals showed significantly increased error starting at 1 day post-
injury when compared to sham controls (SCI: 57.88% ± 15.67%, sham: 5.63% ± 1.21%, 
mean ± sem, p=0.011); this significant difference continued up to 7 day post-injury. At 2 
weeks post-injury, no significant difference was observed. At 3 weeks post-injury, an 
attenuated trend was seen again (p=0.052). No significant difference was seen between SCI 
and sham groups from 4 weeks to 6 weeks post-injury (Fig. 4.6A). For total traveled 
distance, SCI animals showed a trend of decreased total distance at 3 days post-injury 
(p=0.064), followed by a significant difference at 5 days post-injury (p=0.003). From 7 
days to 6 weeks post-injury, there was no significant difference between SCI and sham in 
the total traveled distance (Fig. 4.6B). These data indicated grid walking test could detect 




Figure 4.6. Grid walking. 
(A-B) Between Sham and SCI groups, both percentages of foot fall and total distance 
travelled during grid walking were recorded up to 6 weeks. (C-D) Between SCI + Saline 
and SCI + FA-GC groups, both percentages of foot fall and total distance travelled during 
grid walking were recorded up to 6 weeks. Error bars represent ± SD. n=4 for the sham 
group, n=3 for SCI and SCI + saline groups, and n=8 for SCI + FA-GC group.  * P<0.05, 
** P<0.01, *** P<0.001.    
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No significant difference was found between FA-GC treated and saline-treated 
animals for the first three days post-injury. A slight but not significant improvement was 
seen in FA-GC treated animals at 5 days post-injury when compared to saline-treated 
controls (p=0.063). From 7 days to 6 weeks post-injury, no significant difference has been 
observed except at 3 weeks post-injury (p=0.004) (Fig. 4.6C). For total traveled distance, 
no significant difference was found at any particular timepoint (Fig. 4.6D). FA-GC 
treatment appeared to have no positive influence on the early functional deficits shown in 
the grid walking test. 
 
Part III: modified grip strength  
To test the muscular strength of forelimbs, the force of grip strength was evaluated. At 2 
days post-injury, SCI induced a significant reduction in grip strength compared to sham 
controls (p=0.0023). This phenomenon was persistent up to 6 weeks post-injury (Fig. 
4.7A). This result indicated grip strength was sensitive to distinguish the difference 
between SCI and sham controls. 
At 2 days post-injury, both FA-GC and saline-treated SCI animals displayed SCI-
induced reduction of grip strength compared to baseline (FA-GC: p=<0.0001; saline: 
p=0.001). FA-GC treated animals did not show any significant improvement in grip 
strength until 2 weeks post-injury when compared to saline controls (p=0.0003). At 3 
weeks post-injury, FA-GC treated animals continuously showed significantly improved 
grip strength (p=0.0008). At 4 weeks post-injury, there was a continued trend of 
improvement in FA-GC treated group compared to saline controls (p=0.08). At 5 weeks 
post-injury, FA-GC treated animals again showed significantly improved grip strength (p<  
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Figure 4.7. Modified grip strength. 
The measurements of grip strength force were recorded up to 6 weeks (A) between Sham 
and SCI groups, and (B) between SCI + Saline and SCI + FA-GC groups. The changes of 
body weight were also recorded up to 6 weeks (C) between Sham and SCI groups, and (D) 
between SCI + Saline and SCI + FA-GC groups. Error bars represent ± SD. n=4 for the 
sham group, n=3 for SCI and SCI + saline groups, and n=8 for SCI + FA-GC group.  * 
P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001.    
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0.0001). No significant difference was observed at 6 weeks post-injury (Fig. 4.7B). 
Interestingly, all four groups showed an ascending trend of grip strength over time. 
This phenomenon may be caused by two reasons: changes in body weight and the exercise 
effect brought by the repeated tests. Indeed, I found the body weight increased significantly 
over time (p<0.0001), but there was no significant difference in the ascending trend of 
neither sham vs. SCI groups (Fig. 4.7C, p=0.4568, p>0.05), nor FA-GC vs. saline-treated 
groups (Fig. 4.7D, p=0.2565, p>0.05). 
 
Part IV: rotarod 
Two parameters were assessed in the rotarod test: latency and speed when falling off the 
rod. For latency, both SCI animals and sham controls showed no significant difference at 
baseline (sham: 74.0 ± 6.3 sec, SCI: 75.7 ± 7.0 sec, mean ± sem, p=0.867). At 2 days post-
injury, both SCI and sham groups had short latencies on the rod (Sham: 41.0 ± 14.1 sec, 
SCI: 3.7 ± 7.0 sec, mean ± sem, p=0.077). At 4 days post-injury, SCI animals spent 
significantly less time on the rod compared to sham controls (Sham: 47.5 ± 9.1 sec, SCI: 
14.0 ± 5.0 sec, p=0.034). From 6 days to 6 weeks post-injury, no significant difference was 
observed between sham and SCI groups (Fig. 4.8A). The speed comparison between sham 
and SCI groups was very similar to the latency. At 2 days post-injury, a slight but not 
significant trend was shown (p=0.056). At 4 days post-injury, SCI animals showed 
significantly slower speed compared to sham controls (p=0.035). No significant difference 
was observed from 6 days to 6 weeks post-injury (Fig. 4.8B). Neither latency nor speed, 
FA-GC treated animals did not show any significant difference across all testing timepoints 




Figure 4.8. Rotarod. 
(A-B) Between Sham and SCI groups, both latency and speed during rotarod were recorded 
up to 6 weeks. (C-D) Between SCI + Saline and SCI + FA-GC groups, both latency and 
speed during rotarod were recorded up to 6 weeks. Error bars represent ± SD. n=4 for the 




The intent of this study was to assess whether FA-GC can seal the damaged blood vessels 
following SCI. My results showed that intravenous delivery of FA-GC could effectively 
reduce the vascular leakage in the transitional zone, contributing to acute neuroprotection 
and partial recovery of forelimb functions. Although FA-GC was tested in a thoracic injury 
model and demonstrated a neuroprotective effect before (Wu et al., 2014), my current study 
does not simply replicate its effect at another cord level. Rather, I revealed a new 
mechanism of FA-GC action on the blockade of acute vascular damages. The results can 
also be a proof of concept that early vascular injuries from the transitional zone exacerbate 
secondary damage of the local neurons.  
 
A novel vascular-based strategy treating SCI 
My study is novel as it is using a nanoparticle to seal the damaged blood vessels treating 
SCI. Previous work attempted on targeting vascular mechanisms following SCI mostly 
focused on posttraumatic hypotension/ischemia. Their strategies involved whole-blood 
transfusion or administration of dopamine to raise the spinal cord blood flow, resulting in 
no functional improvement (Dolan and Tator, 1982). This may be due to the risk of 
ischemia-reperfusion injury. My work aimed to target increased vascular permeability, 
which put the spinal cord in risk exposing to the toxic effects of inflammatory cells. Both 
hemorrhage and plasma protein extravasation from the disrupted blood vessel are 
neurotoxic (Bell et al., 2012, Zhong et al., 2008). However, the underlying mechanisms of 
barrier disruption and vascular leakage contributing to neurotoxicity remain elusive. Thus, 
my study could provide more information and potentially a promising strategy. 
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FA-GC effectively reduced vascular leakage and prevented neuronal loss  
Wu et al. previously demonstrated targeted distribution of FA-GC in the injured spinal cord 
using a fluorescent-tagged FA-GC (Fig. 4.1E) (Wu et al., 2014). Here I showed a positive 
effect of FA-GC on reducing SCI-induced vascular leakage in vivo (Fig. 4.2). This 
evidence collectively suggests that FA-GC can prevent vascular leakage by sealing the 
damaged vascular membrane. Although the previous study has shown a significant 
locomotion recovery with FA-GC treatment, its exact mechanism contributing to 
functional recovery remained obscure. My data provided strong circumstantial evidence of 
FA-GC on repairing the microvasculature. 
Next, the histological evidence showed FA-GC reduced the loss of ventral horn 
neurons in the transitional zone (Fig. 4.3). Ferulic Acid (FA), a derivative of curcumin, 
exhibited neuroprotective effects via anti-oxidative, anti-apoptotic, and anti-excitotoxic 
effects in various animal models (Cheng et al., 2010, Sung et al., 2014, Lin et al., 2013). 
On the other hand, chitosan-based therapy has been shown to promote vascular hemostasis 
and decrease blood loss (Hoekstra et al., 1998, Esposito et al., 2013, Kunio et al., 2013). 
The significance of my study is that I demonstrated FA-GC could prevent neuronal loss 
from secondary degeneration under the dual properties of neuroprotection and hemostasis. 
 
Behavior deficits of cervical spinal cord injury model and forelimb functional recovery 
of FA-GC treatment  
Since I observed histological evidence of neuroprotection by FA-GC treatment, it was of 
my interest to assess whether this improvement translated into functional recovery. 
However, there was no characterization of the functional deficits in my cervical SCI model 
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yet. Thus, I first established the baseline of behavioral deficits in this specific injury model. 
I chose to assess four behavioral tests, including grip strength, adhesive removal, grid 
walking, and rotarod. The grip strength is utilized to assess forelimb muscle strength 
(Takeshita et al., 2017), whereas the adhesive removal test is used to test somatosensory 
dysfunction (Komotar et al., 2007). Both rotarod and grid walking were chosen to test 
motor function and coordination of the forelimb/hindlimb function (Shiotsuki et al., 2010, 
Horvath et al., 2015). In the present study, a C7 midline contusive SCI model showed the 
main behavioral deficits in forelimb muscle strength. No significant difference was shown 
in somatosensory functional impairment. Only early deficit was observed in the motor 
coordination of the forelimb/hindlimb function. 
In the FA-GC treated animals, my behavior data showed significant improvement 
of forelimb muscle strength over 6 weeks post-injury. This is consistent with my 
histological results that neurons in the ventral horn, mostly motor neurons, were saved with 
FA-GC treatment. A retrograde tracing study suggests that motor neurons in the lower 
cervical spinal cord innervate forelimb muscles, including biceps brachii, triceps brachii, 
and deltoid, etc (Bacskai et al., 2013). However, no significant difference was detected in 
the other three behavioral tests. It is possible that the sensitivity of these behavior 
measurements was not optimal for this specific injury model. On the other hand, another 
possibility is due to the lack of optimal drug concentration.    
 
Future studies 
Here my study on the effects of FA-GC treatment was only preliminary. To investigate the 
maximum effect of FA-GC on preventing post-injury vascular disruption, FA-GC was 
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designed to be delivered within 15 minutes after SCI. Additional studies which deliver FA-
GC at different time points after injury are required to explore a clinically feasible time 
window of delivery. Also, future studies will be performed to understand the mechanisms 
of FA-GC-mediated vascular permeability changes and repair. An in vitro Blood-Brain 
Barrier (BBB) model with a monolayer of human brain microvascular endothelial cells 
(HBMEC) has been successfully established. In this in vitro model, I can examine the 
barrier properties after injury and FA-GC treatment, including permeability and 
transendothelial electrical resistance (TEER). Using immunofluorescent staining and 
westernblot, I can also assess the structural and molecular changes in the endothelial cell 
layer. Several junctional proteins can be tested, such as occludin, claudin-6, vascular 
endothelial cadherin (VE-Cadherin), and F-actin. 
In summary, the results of this study suggest that the intravenous delivery of FA-
GC effectively improved the progressively disrupted vascular changes, promoted acute 
neuroprotective benefits and a partial role in long-term functional recovery after an acute 
SCI. Albeit additional studies will be needed to further address the mechanism and 
potential clinical applications of FA-GC, my results affirm FA-GC as an effective 
neuroprotective drug that can target microvasculature repair in the acute phase of SCI.  
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CHAPTER 5  
CONCLUSIONS 
 
Spinal cord injury (SCI) is a major public health issue in the United States and an 
unmet medical need. Nowadays, more than a quarter of a million Americans experience 
SCI (NSCISC, 2019). Unfortunately, there is no effective treatment available. It is well-
known that a cascade of vascular events occurs immediately following spinal cord injury 
(SCI). However, the acute vascular dynamic changes and underlying mechanisms have 
been understudied. 
One major reason impeding research in vascular injury following SCI is the 
technical limitation – most analyses have been performed on post-mortem samples and are 
unable to capture the dynamic changes of the vascular network under traumatic conditions. 
It is important to develop a tool that teases out the mechanism and contributes information 
to find potential targets for treatment. In chapter 2, I reported a two-dye in vivo imaging 
method, using two-photon laser scanning microscopy (TPLSM), which can overcome the 
technical barricades and monitor acute vascular dynamic changes following contusive SCI. 
This approach allows detecting blood flow and vessel diameter at various sites of the same 
rat pre- and post-injury, as well as other vascular pathology. Using this tool, my preliminary 
study found an unconventional phenomenon that SCI acutely induced an immediate 
vascular disruption which was beyond the direct impact site. This finding was different 
from the conventional concept on the progression of SCI, which facilitated my next study 
characterizing a temporospatial profile of vascular and cellular changes following SCI. 
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In the characterization study, I hypothesized that there is a “transitional zone” in 
the non-epicenter regions, where vascular disruptions occur before other cellular damages. 
To identify this “transitional zone”, I analyzed three regions of the cervical spinal cord at 
injury epicenter (C7), adjacent area (C6) and remote zone (C5). The definition of 
“transitional zone” is that the non-epicenter spinal cord region where immediate vascular 
damage occurs and no signs of other cellular changes yet. Therefore, the area of 
“transitional zone” can vary based on animal models and injury severity. My results first 
affirmed that vascular changes went beyond the direct injury site after SCI. Collectively 
my data suggest that vascular damage has occurred in the transitional zone before any other 
cellular responses to the injury, which indicates a time window to delay or rescue neuronal 
and axonal loss at the transitional zone. This is against the conventional view, which claims 
the secondary injury is a result of the expansion from the initial injured site. My conclusion 
is that there is a time window between vascular injury and cellular changes in the 
transitional zone. This leads me to consider the potential involvement of local vascular 
damages on secondary degeneration of cord tissue. In the present study, I only observed 
transitional and remote zones rostral to the injury. I anticipate that caudal representative 
regions may also present with similar changes. The rationale behind this prediction is that 
each spinal cord segment receives blood irrigation from the segmental spinal artery 
bidirectionally, not a simple rostral-to-caudal pattern of blood circulation. However, for 
the animal welfare purpose, I did not expose too long of the spinal cord segments. This 
prediction needs further experimental pieces of evidence for confirmation. As of now, I 
also could not differentiate if the cause of the secondary injury is either local degeneration 
or expansion from the injury epicenter at the late stage of injury. A third possibility is that 
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both processes contribute to the secondary degeneration. By illustrating the phenomenon 
above, I may partially unveil an alternative hypothesis to explain the progression of 
secondary injuries after a contusive spinal cord injury. Also, targeting these early vascular 
responses and protecting vascular integrity at an acute phase of SCI could provide early 
neuronal protection and delay the expansion of damaged tissue in the spinal cord. 
In the third study, I hypothesized that a nanoparticle called FA-GC could seal the 
leaking blood vessels and prevent further vascular leakage, thereby less secondary 
degeneration, and better functional recovery. My results showed the effects of FA-GC on 
the improvement of the vascular damages, which provided neuroprotective effects and 
functional recovery in forelimb muscle strength in a cervical SCI model. Thus, targeting 
acute vascular injury is a potent therapeutic strategy to prevent secondary degeneration and 
therefore to improve functional recovery. 
Collectively, this work provides some initial hope in a new aspect of 
neuroprotection toward SCI, but still a lot of questions remain to be answered. Future 
studies will further dissect FA-GC’s mechanism of action on microvasculature repair in in 
vitro BBB models. Besides, I can assess the vascular changes caudal to the injury. It is also 
of my interest to see whether it is the same as the rostral part or a completely different 
pattern of changes.  
In summary, the current study developed a new method allowing me to be able to 
monitor/study in vivo dynamic vascular changes after SCI. It reveals potential vascular-
based targets and a time window to prevent vascular injury-induced neuronal damage. It 
also tested a proof-of-concept strategy that targeting vascular leakage using a nanoparticle 
can reduce neuronal loss. Finally, this study sheds light onto the temporal window of acute 
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BSCB opening for effective drug delivery which is crucial to many current pharmaceutical 
clinical studies.  
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APPENDIX 
Below is the statement regarding permission from journals to use my first-author 
published manuscripts in my thesis: 
Part of content in chapter 2 was reused with permission from Journal of Visualized 
Experiments, published by MyJove Corp., Cambridge, MA. 
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